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“We are drowning in information but starved for knowledge.”  
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of	 this	 thesis	 was	 to	 comprehensively	 analyse	 the	 metabolome	 and	 fluxome	 of	 CHO	
cells	 exploring	 how	 the	 metabolism	 is	 affected	 by	 clonal	 variability	 and	 culture	
conditions.	 This	 information	 is	 then	 used	 to	 generate	 hypotheses	 on	 how	metabolic	
wiring	impacts	mAb	production.	
We	started	by	implementing	a	1H-NMR	metabolomics	platform	to	assess	the	metabolic	
footprints	 of	 two	 GS-CHO	 cell	 clones	 expressing	 IgG4	 under	 control	 and	
butyrate-treated	 conditions.	 With	 this	 method,	 we	 could	 accurately	 quantify	 the	
dynamic	 profiles	 of	 about	 40	 metabolites,	 including	 some	 not	 usually	 analyzed	 in	
mammalian	cells	cultures,	such	as	acetate,	pyruvate,	formate,	TCA	cycle	intermediates,	
lipid	 and	 nucleotide	 precursors.	 Noteworthy,	 several	 metabolic	 by-products	
accumulated	 in	 the	 cell	 supernatant	 over	 culture	 time,	 suggesting	 that	 different	
metabolic	 nodes	 could	 be	 targeted	 to	 decrease	 overflow	 metabolism.	 Overall,	 most	
carbon	 and	 nitrogen	 sources	 were	 consumed	 at	 higher	 rates	 during	 the	 exponential	
phase	than	during	the	stationary	phase.		
Then,	 the	 exometabolome	 data	 collected	 for	 the	 different	 clones	 and	 conditions	was	
contextualized	 in	 a	 network	 model	 of	 117	 intracellular	 and	 transport	 reactions	 to	
estimate	the	corresponding	fluxomes	through	metabolic	flux	analysis	(MFA).	While	the	







specific	 productivity.	 Furthermore,	 the	 intracellular	 concentration	 pools	 of	 most	
metabolites	measured	 in	 butyrate-treated	 cultures	were	 2.5-fold	 higher	 (on	 average)	






([1,2-13C]glucose,	 [U-13C/15N]asparagine	 and	 [U-13C/15N]serine).	 Upon	 incubation	 of	 a	
high	producing	GS-CHO	cell	clone	with	each	isotopic	tracer,	we	collected	samples	over	
the	exponential	growth	phase	to	 follow	the	transient	 labelling	profiles	of	 intracellular	
metabolites	 by	 GC-MS	 and	 LC-MS.	 The	 patterns	 produced	 from	 the	 [1,2-13C]glucose	
tracer	 revealed	 a	 high	 diversion	 of	 glucose	 to	 the	 pentose	 phosphate	 pathway	when	
compared	 to	 that	 previously	 published	 for	 non-producing	CHO	 cells	 during	 the	 same	
growth	phase,	suggesting	this	route	as	an	important	source	of	NADPH	for	recombinant	
protein	synthesis.	Another	potential	source	of	NADPH	is	the	flux	through	malic	enzyme,	
the	 high	 activity	 of	 which	 was	 suggested	 by	 the	 labelling	 pattern	 of	 pyruvate	 after	
incubation	 with	 [U-13C/15N]asparagine.	 Noteworthy,	 asparagine	 was	 essential	 for	
replenishing	TCA	cycle	intermediates	as	well	as	for	glutamine	synthesis	in	GS-CHO	cells.	
Together	with	asparagine,	serine	was	confirmed	to	be	a	significant	nitrogen	source	in	
these	cells,	with	 15N	 from	both	amino	acid	 tracers	propagating	 to	many	non-essential	
amino	acids.	
Finally,	with	 the	goal	of	better	evaluating	 the	 importance	of	 asparagine	and	serine	 in	
GS-CHO	metabolism,	we	modulated	 the	 availability	 of	 these	 amino	 acids	 by	 culturing	





dramatic	 increase	 in	 pyruvate	 uptake,	 a	 higher	 ratio	 of	 pyruvate	 carboxylation	 to	
dehydrogenation	 and	 an	 inability	 for	 de	 novo	 asparagine	 synthesis.	 The	 release	 of	
ammonia	 and	 amino	 acids	 such	 as	 aspartate,	 glutamate	 and	 alanine	 were	 deeply	
impacted.	This	confirms	asparagine	to	be	essential	for	GS-CHO	cells	as	the	main	source	
of	 intracellular	nitrogen	as	well	as	having	an	important	anaplerotic	role	for	TCA	cycle	
activity.	 In	 turn,	 serine	 limitation	 also	 negatively	 affected	 culture	 growth	 while	
triggering	 its	 de	 novo	 synthesis,	 confirmed	 by	 label	 incorporation	 coming	 from	
pyruvate,	 and	 reduced	 glycine	 and	 formate	 secretion	 congruent	 with	 its	 role	 as	 a	
precursor	 in	 the	 metabolism	 of	 one-carbon	 units.	 The	 results	 obtained	 suggest	 that	
feeding	 schemes	 of	 asparagine	 or	 serine	 should	 be	 tightly	 tuned	 to	 minimize	 by-
product	formation	while	assuring	biosynthetic	needs.		
Overall,	the	work	performed	in	the	scope	of	this	thesis	contributes	to	unfold	important	
insights	 into	 the	 metabolic	 operation	 of	 the	 industrially	 relevant	 GS-CHO	 cell	
expression	host.	An	in-depth	study	of	the	metabolic	network	of	GS-CHO	cells	allowed	to	
uncover	potential	targets	for	minimizing	overflow	metabolism,	reduce	the	diversion	of	
resources	 to	 by-product	 accumulation	 or	 minimize	 their	 impact	 on	 recombinant	
protein	production.	Also	allowed	to	couple	PPP	and	ME	activities,	important	sources	of	
NADPH,	 with	 a	 high	 productive	 phenotype	 in	 GS-CHO	 cells.	 We	 believe	 that	 these	












hospedeiro	 mamífero	 preferido	 para	 a	 produção	 industrial	 de	 glicoproteínas	
terapêuticas,	 tais	 como	 os	 anticorpos	 monoclonais	 (mAbs,	 do	 inglês	 monoclonal	
antibodies)	usados	para	o	tratamento	de	cancro	e	doenças	imunológicas.	Nestas	células,	
o	 sistema	de	expressão	através	da	glutamina	sintetase	 (GS)	 tem	sido	 frequentemente	
utilizado	para	a	selecção	eficiente	de	clones	de	alto	rendimento	produtivo.	No	entanto,	
o	 conhecimento	 fundamental	 sobre	 o	 comportamento	metabólico	 de	 células	 GS-CHO	
em	 cultura	 e	 o	 seu	 impacto	 sobre	 o	 rendimento	 na	 produtividade	 não	 tem	 sido	
sistematizado.	 O	 objectivo	 geral	 desta	 tese	 foi	 o	 de	 fazer	 uma	 análise	 exaustiva	 do	
metaboloma	e	do	fluxoma	de	células	CHO,	explorando	a	 forma	como	o	metabolismo	é	
afectado	 pela	 variabilidade	 clonal	 e	 condições	 de	 cultura.	 A	 informação	 resultante	
poderá	então	ser	utilizada	para	formular	hipóteses	sobre	o	impacto	que	determinados	
rearranjos	metabólicos	podem	ter	sobre	a	produção	de	mAbs.	
Começámos	 por	 implementar	 uma	 plataforma	 baseada	 em	metabolómica	 através	 de	
RMN	 de	 protão	 para	 avaliar	 os	 perfis	 metabólicos	 de	 dois	 clones	 GS-CHO	 com	
diferentes	níveis	de	expressão	de	uma	imunoglobulina	(IgG4)	em	condições	controlo	e	
tratada	 com	 butirato.	 Com	 este	 método,	 conseguimos	 quantificar	 rigorosamente	 os	
perfis	 dinâmicos	 de	 cerca	 de	 40	metabolitos,	 incluindo	 alguns	 que	 normalmente	 não	
são	 analisados	 em	 culturas	 de	 células	 de	 mamífero,	 tais	 como	 o	 acetato,	 piruvato,	
formato,	 intermediários	 do	 ciclo	 dos	 ácidos	 tricarboxílicos	 (ATC),	 e	 precursores	 de	
lípidos	e	nucleótidos.	De	salientar,	vários	sub-produtos	metabólicos	foram	acumulados	
no	 sobrenadante	 das	 culturas	 ao	 longo	 do	 tempo,	 indicando	 que	 vários	 centros	
metabólicos	podem	ser	alvo	de	acção	no	decréscimo	de	um	metabolismo	exagerado.	De	
uma	forma	geral,	a	maior	parte	das	fontes	de	carbono	e	azoto	foi	consumida	durante	a	





Posteriormente,	 os	 dados	 do	 exo-metaboloma,	 recolhidos	 das	 culturas	 controlo	 ou	
tratadas	 com	 butirato,	 foram	 integrados	 num	 modelo	 metabólico	 com	 117	 reacções	
intracelulares	 ou	 de	 transporte	 celular	 para	 se	 poder	 estimar	 os	 fluxomas	
correspondentes	através	de	uma	metodologia	clássica	de	análise	de	fluxos	metabólicos.	
Apesar	de	ambos	os	clones	apresentarem	fluxos	metabólicos	específicos	semelhantes,	o	
tratamento	 com	 butirato	 teve	 um	 efeito	 significativo	 na	 manutenção	 de	 um	 elevado	
consumo	 de	 nutrientes	 ao	 longo	 do	 tempo	 de	 cultura.	 Isto	 resultou	 num	 	 aumento	
significativo	 do	 estado	 energético	 e	 da	 actividade	 biossintética	 durante	 a	 fase	
estacionária,	 quando	o	 efeito	 sobre	 a	produtividade	específica	 é	 igualmente	 superior.	
Para	além	disto,	as	concentrações	intracelulares	obtidas	para	os	metabolitos	analisados	
foram	 em	média	 2.5	 vezes	 superiores	 quando	 comparadas	 com	 as	 culturas	 controlo.	
Diferenças	 mais	 substanciais	 foram	 detectadas	 para	 a	 glutamina,	 alanina	 e	 citrato	
(cerca	 de	 4	 vezes	 superiores),	 pelo	 que	 estes	 metabolitos	 deverão	 ser	 deverão	 ser	
explorados	 em	 experiências	 futuras	 no	 estudo	 dos	 seus	 efeitos	 na	 produção	 de	
proteínas	recombinantes.	
De	 forma	 a	 obter	 uma	 visão	 mais	 detalhada	 sobre	 o	 metabolismo	 celular,	
nomeadamente	 sobre	 as	 actividades	 relativas	 de	 vias	 metabólicas	 paralelas	 e	 a	
contribuição	 de	 certos	 substratos	 para	 vários	 metabolitos	 intracelulares,	 decidiu-se	
fazer	 estudos	 com	 a	 incubação	 de	 compostos	 marcados	 dos	 três	 metabolitos	 mais	
consumidos	 (glucose-[1,2-13C],	 asparagina-[U-13C/15N]	and	 serina-[U-13C/15N]).	Após	a	
incubação	de	culturas	com	o	clone	de	células	GS-CHO	com	mais	elevada	produtividade	
com	 cada	 um	 dos	 isótopos	 durante	 a	 fase	 exponencial	 do	 crescimento	 celular,	
recolhemos	amostras	ao	longo	do	tempo	para	podermos	seguir	os	perfis	transientes	de	
incorporação	 da	marca	 nos	metabolitos	 intracelulares	 por	 GC-MS	 e	 LC-MS.	 Os	 perfis	
obtidos	através	da	incubação	com	[1,2-13C]glucose,	revelam	um	desvio	significativo	de	
glucose	 através	 da	 via	 das	 pentoses	 fosfatadas	 quando	 comparadas	 com	 culturas	 de	
células	CHO	não-produtivas	durante	a	mesma	fase	de	crescimento,	sugerindo	que	esta	





das	 enzimas	 málicas,	 como	 sugerido	 pela	 incorporação	 de	 isótopos	 observada	 no	
piruvato	 obtido	 através	 da	 asparagina-[U-13C/15N].	 De	 salientar,	 a	 asparagina	 foi	
essencial	 para	 o	 reabastecimento	 de	 intermediários	 do	 ciclo	 ATC,	 tal	 como	 para	 a	
síntese	 de	 glutamina	 em	 células	 GS-CHO.	 Juntamente	 com	 a	 asparagina,	 a	 serina	 foi	
confirmada	 como	 sendo	 uma	 fonte	 de	 nitrogénio	 importante	 nestas	 células,	 tendo-se	
observado	 azoto	 (15N)	 derivado	 de	 ambas	 as	 fontes	 em	 vários	 amino	 ácidos	 não-
essenciais.	




A	 ausência	 de	 asparagina	 no	 meio	 basal	 interrompeu	 o	 crescimento	 celular,	 e	 foi	
associado	a	um	aumento	acentuado	do	consumo	de	piruvato,	um	elevado	rácio	entre	as	




uma	 função	 anaplerótica	 na	 actividade	 do	 ciclo	 ATC.	 	 Por	 outro	 lado,	 a	 limitação	 de	
serina	 também	 afectou	 negativamente	 o	 crescimento	 celular	 tendo	 despoletado	 a	
síntese	 de	 novo	 de	 serina,	 confirmada	 pela	 incorporação	 do	 isótopo	 observada	 no	
piruvato,	 e	 reduziu	a	 secreção	de	glicina	e	 formato,	de	acordo	com	o	 seu	papel	 como	
precursor	 no	 metabolismo	 de	 unidades	 com	 um	 carbono	 unitário.	 Estes	 resultados	
sugerem	 que	 as	 estratégias	 de	 alimentação	 com	 asparagina	 ou	 serina	 devem	 ser	






Em	suma,	 esta	 tese	 contribui	para	o	desvendar	de	 importantes	 fenómenos	biológicos	
no	metabolismo	de	células	GS-CHO	com	alto	relevo	industrial.	O	estudo	aprofundado	da	
rede	 metabólica	 das	 células	 GS-CHO	 permitiu	 identificar	 alvos	 de	 estudo	 para	
minimizar	o	metabolismo	exagerado,	 reduzir	o	 consumo	de	 recursos	dirigidos	para	a	
acumulação	 de	 produtos	 secundários	 ou	 o	 impacto	 sobre	 a	 produção	 de	 proteínas	
recombinantes.	Da	mesma	forma,	permitiu	associar	as	actividades	da	via	das	pentoses	
fosfatadas	 e	 das	 enzimas	 málicas,	 importantes	 fontes	 de	 NADPH,	 a	 um	 fenótipo	 de	
produção	elevada	em	células	GS-CHO.	Julgamos	que	estes	elementos	representam	uma	
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therapeutic	 proteins	 mainly	 due	 to	 their	 ability	 to	 perform	 human-like	 post-
translational	modifications.	The	 first	 therapeutic	protein	produced	 from	recombinant	
mammalian	cells,	 tissue	plasminogen	activator	(tPA),	obtained	market	approval	thirty	
years	 ago	 (reviewed	 by	 Butler	 and	 Spearman	 2014;	 Wurm	 2004).	 Nowadays,	
monoclonal	 antibodies	 (mAbs)	 constitute	 the	 main	 class	 of	 biopharmaceuticals	
produced	from	mammalian	cell	cultures.	The	development	of	antibody-based	products	
has	 increased	 significantly	 over	 the	 years,	 representing	27	%	of	 all	 biologic	products	
approved	as	of	2014	(Walsh	2014).	Global	sales	revenue	for	all	mAb	products	in	2013	
was	nearly	US$75	billion,	representing	the	most	lucrative	single	product	class	(Ecker	et	






and	 cardiovascular	 diseases.	 The	 high	 incidence	 of	 these	 diseases,	 associated	 to	 an	
increasing	 and	 aging	 worldwide	 population	 and	 the	 standard	 of	 living	 in	 emerging	






efficacy	 and	 higher	 stability	 in	 the	 human	 serum	 (Butler	 and	 Spearman	 2014).	
Although	 several	 mammalian	 cell	 lines	 are	 used	 for	 production	 of	 complex	
biopharmaceuticals	 (such	 as	 murine	 myeloma	 cells	 (NS0	 and	 SP2/0),	 human	










Product	 Cell	line	 Company	 Target	 Date	approved	
Entyvio	 CHO	 Takeda	Parma	(USA)	Millenium	(UK)		 Ulcerative	colitis,	Crohn’s	disease	 2014	(USA/EU)	
Sylvant	 CHO	 Janssen	Biotech	(USA)	 Multicentric	Castleman’s	disease	 2014	(USA/EU)	













Kadcyla	 CHO	 Roche/Genentech	(UK)	 Breast	cancer	 2013	(EU/USA)	
Simponi	Aria	 Sp2/0	 Janssen	Biotech	 Rheumatoid	arthritis	 2013	(USA)	
















Xgeva	 CHO	 Amgen	(NL)	 Bone	loss	associated	to	cancer	 2011	(EU)	2010	(USA)	
Yervoy	 CHO	 Bristol-Meyers	Squibb	(UK)	 Melanoma	 2011	(USA/EU)	
Actemra	(USA)	
RoActemra	(EU)	 -	 Roche	(UK)	 Rheumatoid	arthritis	
2010	(USA)	
2009	(EU)	
Arzerra	 NS0	 Navartis/Genmab	(UK)	 Chronic	lymphocytic	leukaemia	
2010	(EU)	
2009	(USA)	








The	 initial	 CHO	 cell	 strain	 was	 isolated	 at	 the	 laboratory	 of	 Theodore	 Puck,	 after	
culturing	cells	derived	from	the	ovarian	tissue	of	a	Chinese	hamster	(Puck	et	al.	1958).	
After	an	unknown	amount	of	culture	 time	the	morphology	of	some	cells	changed	and	
these	 underwent	 spontaneous	 immortalization	 (reviewed	 by	 Wurm	 2013).	 Several	
laboratories	 across	 the	 world	 have	 propagated	 the	 number	 of	 CHO	 cell	 lines	 being	
manipulated,	considerably	increasing	the	genetic	and	phenotypic	diversity	of	the	CHO	
cell	system.		

















cells	 with	 a	 plasmid	 encoding	 the	 gene	 of	 interest	 (GOI)	 and	 a	 functional	 dhfr	 gene,	
successfully	 transfected	cells	 can	be	selected	 in	culture	media	without	HT.	Additional	
selection	pressure	can	be	 introduced	using	stepwise	 increases	 in	the	concentration	of	
methotrexate	 (MTX),	 an	 antagonist	 of	DHFR,	which	 results	 in	 amplified	 copies	 of	 the	
transfected	dhfr	gene	together	with	the	GOI,	consequently	 increasing	the	productivity	
of	the	GOI	(Hacker	et	al.	2009;	Wurm	2013)	(Fig.	1.1A).		
GS-CHO-K1	 cells	 are	 obtained	 from	 the	 transfection	 with	 a	 functional	 glutamine	
synthetase	 gene	 together	 with	 gene	 of	 interest	 on	 the	 same	 plasmid,	 followed	 by	
culture	selection	in	medium	without	glutamine	(Wurm	2013).	Nevertheless,	CHO	cells	
possess	 endogenous	GS	 activity	which	must	 be	 specifically	 inhibited	 by	 low	 levels	 of	























specific	 zinc-finger	 nuclease	 (ZFN)-based	 technology,	 and	 translated	 into	 a	 six-fold	
efficiency	increase	in	cell	line	generation,	when	compared	to	GS-CHO	cells	(expressing	
both	 endogenous	 GS	 activity	 and	 the	 GS	 system)	 	 (Fan	 et	 al.	 2012).	 Posteriorly,	 the	




of	 the	 SV40),	 in	 combination	with	 the	 GS-knockout	 CHO	 cells,	 resulting	 in	 improved	






2013;	Wurm	2004).	 The	mammalian	 cell	 culture	 field	 has	matured	 significantly	 over	
the	years,	and	today	it	is	possible	to	deliver	gram	per	litre	titres	of	product	in	fed-batch	
cultures,	representing	over	100-fold	improvement	since	the	1980s	(Mead	et	al.	2012).	
This	 yield	 improvement	 has	 been	 the	 result	 of	 better	 expression	 vector	 designs,	
improved	 host	 cell	 lines,	 development	 of	 medium	 composition	 and	 feeding	 regimes,	
and	advanced	screening	techniques.		
1.3.1 Culture	medium	and	fed	batch	processes	
Medium	development	 for	mammalian	cells	has	progressed	enormously	 since	 the	 first	
formulations	 that	 required	 serum	 supplementation	 (Bruhlmann	 et	 al.	 2015).	 Fully	
chemically	defined	media	consisting	of	amino	acids,	vitamins,	trace	elements,	inorganic	
salts,	 lipids	 and	 insulin	 or	 insulin-like	 growth	 factors,	 have	 been	 developed	 for	mAb	
production	 processes	 (Pasupuleti	 et	 al.	 2008).	 In	 general,	 medium	 development	 is	
labor-intensive	and	time-consuming,	and	it	is	based	in	statistical	design	of	experiment	
(DoE)	(Kim	and	Lee	2009).		
Not	 all	 antibody	 production	 cell	 lines	 can	 achieve	 high	 yield	 in	 chemically	 defined	
media.	Therefore,	 the	addition	of	non-animal	hydrolysates	(composed	of	amino	acids,	
small	 peptides,	 carbohydrates,	 vitamins	 and	minerals)	 became	 a	 common	 strategy	 in	
order	 to	maximize	cell	density,	 culture	viability	and	productivity	 (Kim	and	Lee	2009;	
Michiels	 et	 al.	 2011).	 However,	 because	 of	 its	 composition	 complexity	 and	 lot-to-lot	
variations,	hydrolysates	can	be	a	significant	source	of	medium	variability.	








Perfusion	 has	 been	 used	 also	 like	 fed-batch	mode	 for	 the	 production	 of	 recombinant	
proteins	in	mammalian	cell	cultures.	In	fact,	the	highest	volumetric	productivities	have	
been	 achieved	 using	 continuous	 stirred	 tank	 bioreactors	 in	 perfusion	 mode,	 using	













quality	 (Al-Fageeh	 et	 al.	 2006).	 For	 instance,	 Yoon	 et	 al	 showed	 a	 significant	
improvement	 in	 specific	 productivity	 of	 erythropoietin	 (EPO)	 and	 follicle-stimulating	
hormone	 (FSH)	 when	 decreasing	 culture	 temperature	 from	 37	 to	 32	 °C	 (Yoon	 et	 al.	
2006).	Several	chemicals	have	been	applied	as	productivity	enhancers	for	recombinant	
protein	production	 in	 cultured	mammalian	 cells,	 including	dimethylsulfoxide	 (DMSO)	
(Allen	et	al.	2008),	sodium	butyrate	(NaBu)	(Yee	et	al.	2008)	and	rapamycin	(Balcarcel	
and	 Stephanopoulos	 2001).	 In	 particular,	 sodium	butyrate	 has	 been	used	 to	 improve	
the	production	of	tPA	(Palermo	et	al.	1991),	EPO	(Wang	et	al.	2011),	mAb	(Mimura	et	al.	
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2001)	and	human	prolactin	 (hPRL)	 (Goulart	et	al.	2010).	NaBu	has	 several	effects	on	
cultured	 cells,	 namely	 growth	 inhibition,	 induction	 or	 repression	 of	 gene	 expression	
and	 induction	 of	 apoptosis	 (Jiang	 and	 Sharfstein	 2008).	 NaBu	 regulates	 gene	
transcription	 by	 improving	 gene	 accessibility	 through	 the	 inhibition	 of	 histone	
deacetylases	 (HDAC)	 (Jiang	 and	 Sharfstein	 2008).	 When	 hyper	 acetylated	 histones	
become	more	 relaxed	 complexes	with	 DNA,	 genes	 are	more	 accessible	 to	 regulatory	
factors	and	thus	transcribed	at	higher	rates.		
Although	these	strategies	managed	to	boost	productivities	and	yields,	they	have	to	be	




A	 significant	 amount	 of	 work	 has	 been	 done	 to	 genetically	 engineer	 host	 cells	 to	
improve	 their	 robustness,	 enhance	 their	 specific	 productivity	 or	 improve	 product	
quality	(Le	et	al.	2015).	Cell	engineering	efforts	usually	target	the	machinery	of	several	




these	 mechanisms,	 or	 the	 introduction	 of	 other	 genes	 (Fischer	 et	 al.	 2015).	 A	 lot	 of	
attention	has	been	 given	 to	 anti-apoptosis	 engineering	 as	 a	main	 strategy	of	 cell	 line	
development	 for	 protein	 production	 (Majors	 et	 al.	 2007).	 Anti-apoptosis	 approaches	
rely,	 at	 a	 first	 instance,	 on	 the	 overexpression	 of	 anti-apoptotic	 genes	 held	 by	
mammalian	 cells.	 These	 genes	 encode	 for	 anti-death	 proteins	 that	 prevent	 the	
activation	of	the	apoptosis	cascade.	Among	these,	with	positive	results	in	terms	of	cell	
density	and	protein	titre	are	Bcl-2,	Bcl-xL	and	30Kc6	(Figueroa	et	al.	2007;	Mastrangelo	
et	 al.	 2000;	 Wang	 et	 al.	 2011).	 A	 second	 approach	 to	 avoid	 apoptosis	 has	 been	 the	
inhibition	of	caspase	expression,	since	the	activation	of	members	of	the	caspase	family	




is	 part	 of	 the	 cellular	 processes	 that	 lead	 to	 apoptosis	 (Laken	 and	 Leonard	 2001;	
Mimura	et	al.	2000).	Thirdly,	the	inhibition	of	cell	cycle	progression	as	this	significantly	
increases	cell	density	and	productivity	in	mammalian	cell	cultures.	These	strategies	led	
to	 a	 slower	 cell	 cycle	 that	 lead	 to	 an	 extended	 cell	 viability	 through	 time	 and,	
consequently,	 an	 increased	 specific	mAb	 productivity	 (Balcarcel	 and	 Stephanopoulos	
2001).	 Recently,	 Tan	 et	 al	 (2015)	 introduced	 heat	 shock	 protein	 27	 in	 CHO	 cells	 in	





control	 the	medium	pH.	A	 significant	 amount	 of	work	has	 been	performed	 to	 reduce	
lactate	and	ammonia	accumulation;	strategies	 include	the	partial	disruption	of	 lactate	
dehydrogenase	A	(LDH-A)	gene,	or	the	overexpression	of	pyruvate	carboxylase	(PYC2),	









Figure	 1.2	 Classical	 and	 cell	 engineering	 approaches	 to	 improve	 the	 specific	 productivity	 of	 CHO	 cells.	
Inside	 the	 CHO	 cell	 representation	 are	 presented	 the	 common	 targets	 of	 cell	 engineering	 approaches	
(Fischer	et	al.	2015;	Le	et	al.	2015).	
Very	 recently,	Wilkens	 and	Gerdtzen	 (2015)	 compared	different	 engineered	CHO	 cell	
clones	with	overexpression	of	 several	metabolic	genes,	namely	PYC2,	MDH	II	 (malate	
dehydrogenase	 II)	 and	 GLUT5	 (fructose	 transporter),	 in	 terms	 of	 their	 effect	 on	 IgG	
production	 performance.	 Although	 previous	 studies	 had	 reported	 improved	 specific	
productivities	when	overexpressing	these	genes	(Chong	et	al.	2010;	Irani	et	al.	1999;	Le	
et	 al.	 2013),	Wilkens	 study	 did	 not	 corroborate	 those	 studies.	 They	 propose	 that	 the	
modifications	promote	an	unbalanced	redox	state	which	may	have	a	negative	impact	on	
IgG	assembly	and,	consequently,	reducing	its	secretion.		
Glycosylation	 pathway	 engineering	 has	 also	 received	 considerable	 attention	 because	
glycan	 structures	 on	 antibodies	 can	 have	 substantial	 impact	 on	 clearance	 rate	 and	
bioactivities.	 For	 instance,	 gene	 deletion	 technologies	 have	 been	 used	 to	 decrease	 or	
eliminate	 the	 fucose	 on	 antibodies	 to	 dramatically	 improve	 antibody-dependent	
cellular	 cytotoxicity	 (ADCC)	 (Malphettes	 et	 al.	 2010).	 	 In	 particular,	 non-fucosylated	
antibodies	present	a	substantially	higher	efficacy	 than	 their	 fucosylated	counterparts,	
in	 most	 cases,	 due	 to	 a	 higher	 ADCC	 activity	 (Konno	 et	 al.	 2012).	 However,	 these	




approaches	 are	 often	 host	 cell	 dependent,	 as	 each	 host	 has	 its	 own	 specific	 post-
translational	modifications	fingerprint.		
1.4 Systems	biotechnology	
With	 the	progress	made	 in	Omics	 technologies	 in	 last	10	years,	 it	became	possible	 to	
study	the	molecular	traits	that	characterize	a	high-producer	cell	(reviewed	by	Carinhas	
et	 al.	2012).	High-throughput	experimental	 techniques	and	superior	 computer	power	
have	 permitted	 obtaining	 great	 amounts	 of	 Omics	 data,	 allowing	 to	 gain	 in-depth	
knowledge	 of	 biological	 processes.	 Although	 we	 cannot	 integrate	 yet	 all	 levels	 of	
information,	we	can	use	parts	of	it	to	determine	new	targets	for	host	improvement	(Lee	
et	 al.	 2005).	 The	 recent	 sequencing	 of	 CHO	 genome,	 combined	 with	 advances	 in	
technologies	 that	allow	a	better	 characterization	of	 the	proteome	and	metabolome	of	
cells	under	different	environments,	may	now	permit	a	comprehensive	understanding	of	





al.	 2016).	 DNA	 microarrays	 have	 revolutionized	 the	 quantitative	 analysis	 of	 gene	
expression	as	 they	allow	covering	a	 large	number	of	genes	simultaneously	 in	a	single	
assay.	This	genome-scale	technology	has	been	applied	to	i)	investigate	gene	expression	
under	 culture	 conditions	 that	 enhance	 productivity,	 including	 temperature	 shifts,	
butyrate	treatment,	and	high	osmolality	(Gatti	et	al.	2007;	Kantardjieff	et	al.	2010),	 ii)	
to	compare	CHO	cell	lines	expressing	different	levels	of	recombinat	protein	(Clarke	et	al.	
2011;	 Doolan	 et	 al.	 2010;	 Kang	 et	 al.	 2014),	 or	 iii)	 at	 different	 culture	 stages.	 For	
instance,	 Wong	 and	 co-workers	 applied	 comparative	 transcriptomic	 analysis	 to	 find	
key	factors	regulating	the	apoptosis,	which	occurs	at	the	later	stages	of	batch	and	fed-
batch	cultures	(Wong	et	al.	2006a;	2006b).	Overexpressing	the	identified	anti-apoptotic	
genes	 (Fadd	 and	 Faim),	 or	 knocking	 down	 the	 pro-apoptotic	 genes	 (Alg-2,	 and	
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performance	 of	 CHO	 cells.	 Main	 goals	 for	 Omics	 approaches	 (upper	 arrows)	 and	 main	 insights	 (lower	
arrows)	to	be	obtained	or	predicted	(Chen	et	al.	2016;	Kildegaard	et	al.	2013;	Lewis	et	al.	2016).		
	
MicroRNAs	 are	 a	 class	 of	 small	 non-coding	 RNAs	 that	 can	 regulate	 global	 gene	
expression	 at	 the	 post-transcriptional	 level	 by	 mRNA	 cleavage	 or	 translational	
repression,	or	both.	The	ability	of	microRNAs	to	bind	multiple	target	genes	and	regulate	
their	 abundance	 has	 made	 them	 significantly	 interesting	 for	 CHO	 cell	 engineering	
(Barron	 et	 al.	 2011).	 There	 are	 several	 studies	 focused	 on	 improving	 productivity,	
either	through	miRNA	overexpression	or	knockdown	(Fischer	et	al.	2015).	Jadhav	and	
co-workers	 managed	 to	 improve	 cell	 growth	 and	 enhance	 the	 specific	 protein	
productivity	of	CHO	cells	(3-fold)	through	the	stable	overexpression	of	miR-17	(Jadhav	
et	 al.	 2014).	 The	 stable	 miR-30	 overexpression	 in	 CHO	 cells	 allowed	 to	 improve	










cell	 culture	 engineering	 (Griffin	 et	 al.	 2007).	 Proteomics	 has	 been	 applied	 to	 identify	
differentially	 expressed	 proteins	 that	 may	 have	 an	 impact	 in	 cell	 growth	 and	 death,	
metabolism	and	protein	processing,	 including	glycosylation	(Baycin-Hizal	et	al.	2012).	
Since	the	transcriptome	and	the	proteome	might	not	be	directly	correlated,	combined	
approaches	 are	 often	 chosen	 in	 order	 to	 deepen	 our	 understanding	 of	 cellular	
physiology	 (Baycin-Hizal	 et	 al.	2012).	For	 instance,	Doolan	and	co-workers	 combined	
microarray	 and	 proteomic	 expression	 profiling	 of	 CHO	 cells	 to	 identify	 genes	 and	
proteins	involved	in	high	cell	growth	rates	and	protein	production	(Doolan	et	al.	2010).	
21	 targets	 were	 identified	 and	 associated	 to	 high	 growth	 rate,	 from	 which	 5	 were	
validated	 by	 siRNA	 knockdown	 and	 considered	 feasible	 for	 further	 studies.	 More	
recently,	multiple	mAb-producing	CHO	cell	lines	were	compared	through	a	multiomics	
approach,	 including	 microarray-based	 transcriptomics	 and	 LC-MS/MS	 shotgun	
proteomics,	 in	order	to	 identify	 features	associated	to	a	high	productivity	(Kang	et	al.	
2014).	 This	 approach	 allowed	 identifying	 several	 potential	 genes	 and	 proteins	
associated	to	productivity,	cell	size	and	proliferation.	
1.4.2 Metabolome	and	Fluxome	layers	
Although	 metabolomics	 had	 been	 shadowed	 by	 genomics,	 transcriptomics	 and	
proteomics,	 it	 has	 reached	 a	 “golden	 era”	 potentiated	 by	 analytical	 techniques	 and	
computational	 power	 (Idle	 and	Gonzalez	2007).	The	 comprehensive	quantification	of	
the	cellular	metabolome	(the	collection	of	metabolites	at	any	given	time)	can	be	carried	
out	 by	 state-of-the-art	 analytical	 approaches	 based	 on	 nuclear	 magnetic	 resonance	
(NMR)	or	mass	spectrometry	(MS)	(Fig.	1.3).		
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Obtaining	 an	 accurate	 snapshot	 of	 cellular	 metabolite	 levels	 is	 dependent	 of	 several	
delicate	 steps,	 which	 address	 significant	 challenges	 inherent	 to	 physicochemical	
diversity,	variety	and	rapid	turnover	of	metabolites	in	mammalian	cells.	The	sampling	
and	arrest	of	metabolic	activity	(usually	achieved	by	the	use	of	a	quenching	solution	at	
low	 temperatures)	 should	 be	 fast	 to	 prevent	 significant	 changes	 in	 metabolite	
concentrations	 due	 to	 ongoing	 metabolic	 activity.	 	 As	 opposed	 to	 extracellular	
metabolites	 that	 can	 be	 easily	 quantified	 through	 supernatant	 analysis,	 the	 accurate	
quantification	of	intracellular	metabolite	pools	is	dependent	also	of	an	extraction	step.	
Furthermore,	MS	analysis	 is	usually	preceded	by	separation	and	 ionization	steps	 that	
allow	 reducing	 the	 complexity	 of	 a	 biological	 sample	 and	 the	 analysis	 of	 a	 smaller	
number	of	metabolites	at	different	retention	times	(Alonso	et	al.	2015).	Liquid	and	gas	
chromatography	(LC	and	GC,	respectively)	are	the	most	common	separation	techniques.		
Additionally,	 after	 data	 acquisition	 through	 NMR	 or	 MS,	 spectral	 data	 must	 be	
processed	 through	 several	 sequential	 steps	 aimed	 at	 accurately	 identifying	 and	
quantifying	the	metabolites	present	in	a	culture	sample,	including	baseline	correction,	
peak	 detection	 or	 spectral	 alignment.	 Peak	 overlapping	 issues	 require	 deconvolution	
methods;	several	software	are	currently	available	to	facilitate	spectra	integration,	such	
as	Chenomx	NMR	Suite	or	Agilent	MassHunter.		
Metabolomics	 tools	 have	 been	 used	 to	 support	 animal	 cell	 process	 development.	 For	
instance,	Sellick	et	al.	(2011b)	developed	a	feeding	approach	based	on	the	identification	
of	 limiting	 nutrients	 in	 a	 mAb-producing	 CHO	 cell	 culture	 by	 GC-MS	 analysis.	 By	
supplying	 the	 limiting	 nutrients,	 the	 biomass	 could	 be	 increased	 by	 35	 %	 and	 the	
antibody	titre	could	be	doubled	(Sellick	et	al.	2011a).	In	another	MS-based	study,	Chong	
et	 al.	 (2010)	 found	 a	 high	 accumulation	 rate	 of	 malate	 in	 the	 medium	 of	 CHO	 cells.	
Subsequent	 cell	 engineering	 to	 overexpress	 malate	 dehydrogenase	 II	 resulted	 in	
significant	growth	improvement.	




On	the	other	hand,	 it	 is	the	fluxome	(collection	of	metabolic	 fluxes	 inside	the	cell)	the	
actual	target	of	considerable	attention	as	it	reflects	the	final	output	of	the	interactions	
between	 genome,	 transcriptome,	 proteome	 and	metabolome	 layers;	 and	 it	 is	 closely	
related	 to	 the	 cells	 phenotype	 (Sauer	 2006).	 As	 opposed	 to	 transcripts,	 proteins	 and	
metabolites,	fluxes	cannot	be	measured	directly	and	they	have	to	be	inferred	from	data	
through	 model-based	 interpretation.	 Mathematical	 models	 became	 essential	 to	
quantify	 the	 cellular	metabolism	under	different	 culture	 conditions,	 and	generate	 the	
knowledge	needed	to	optimize	the	performance	of	cell	factories.	
When	metabolic	 steady-state	 can	 be	 assumed,	metabolic	 flux	 analysis	 (MFA)	 became	
the	 preferential	 technique	 to	 obtain	 quantitative	 information	 about	 in	 vivo	 cellular	
metabolism	 (Wiechert	 2001).	 Thus,	 MFA	 can	 provide	 the	 knowledge	 to	 allow	 a	
manipulation	of	metabolic	fluxes,	in	order	to	obtain	improved	process	yields	and	better	
quality	attributes	in	biopharmaceuticals	production	(Sá	et	al.	2015).	
Classical	 (or	 stoichiometric)	 MFA	 is	 based	 on	 the	 flux	 balancing	 of	 intracellular	
metabolites	within	a	stoichiometric	matrix,	 in	which	extracellular	measurements	such	
as	 nutrient	 uptake,	 by-product	 secretion	 and	 growth	 rate	 are	 used	 as	 constraints	 to	
determine	 intracellular	 fluxes	 (Antoniewicz	 2015).	 Such	 stoichiometric	 flux	 analysis	
can	 provide	 a	 good	 snapshot	 of	 the	 fluxome	 state,	 allowing	 for	 instance	 a	 broad	
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(mAb	 –	 monoclonal	 antibody;	 glc	 –	 glucose;	 pyr	 –	 pyruvate;	 gln	 –	 glutamine;	 INST	 –	 isotopically	 non-
stationary;	NMFA	–	non-stationary	MFA;	GS	–	glutamine	synthetase;	DHFR	–	dihydrofolate	reductase)		
Complementing	 extracellular	 data	 with	 isotopic	 labeling	 information	 in	 13C-MFA	
studies	provides	higher	resolution,	allowing	to	detect	even	the	more	subtle	differences	
in	 flux	 phenotypes.	 An	 isotopic	 tracer	 is	 a	molecule	 where	 a	 specific	 atom	 has	 been	
replaced	with	a	different	stable	isotope,	usually	13C,	15N	or	2H.	When	labeled	versions	of	
nutrients	are	added	to	cells,	the	label	propagates	through	the	network	as	a	function	of	
metabolic	 activity,	 producing	 labeling	 patterns	 in	 the	 backbone	 of	 metabolic	
intermediates	over	time.	Mathematical	models	describing	this	propagation	of	the	label	








of	 parallel,	 reversible	 or	 cyclic	 pathways	 (Crown	 and	 Antoniewicz	 2012;	 Quek	 et	 al.	





A	recent	 trend	to	resolve	 intracellular	pathways	has	been	the	use	of	parallel	 labelling	
experiments.	 This	 technique	 has	 been	 addressed	 as	 COMPLETE-MFA	 –	 short	 for	
complementary	 parallel	 labelling	 experiments	 technique	 for	 metabolic	 flux	 analysis.	
This	 method	 results	 from	 fitting	 several	 data	 sets	 from	 several	 experiments	 into	 a	
single	 flux	 model	 (Antoniewicz	 et	 al.	 2007).	 The	 main	 advantage	 is	 that	 it	 allows	
producing	 results	 with	 increased	 accuracy	 over	 13C-MFA	 (Antoniewicz	 2015).	 This	
approach	minimizes	the	issue	of	selecting	the	best	single	tracer	that	would	allow	a	good	
screening	of	 the	whole	network	and	with	a	 good	 resolution	 (Crown	and	Antoniewicz	
2012).	
1.5 Thesis	motivation	and	outline		
Up	 to	 now,	 cell	 engineering	 has	 encompassed	 intuitive	 manipulations	 of	 enzyme	
activities,	 allowing	 slight	 improvements	 in	 yields	 and	 quality	 of	 therapeutic	 protein	
production.	 More	 efficient	 production	 requires	 deeper	 understanding	 of	 cellular	
metabolism	and	 its	regulation,	which	provides	the	building	blocks	and	energy	 for	cell	
growth	and	recombinant	protein	production.		
This	 thesis	 aims	 at	 studying	 the	 central	 metabolism	 of	 producer	 cells	 in	 order	 to	




GS-CHO	 cell	 clones	 cutured	 in	 control	 and	 butyrate-treated	 conditions	 was	 analysed	






and	 ammonia.	 This	 data	was	 then	 integrated	 into	 an	 extended	metabolic	 network	 to	
estimate	 the	 in	 vivo	 fluxes	 in	 different	 productivity	 states	 using	 MFA,	 to	 identify	
metabolic	 features	 correlated	 with	 higher	 productivity.	 In	 chapter	 3,	 we	 performed	
short-term	 parallel	 labelling	 experiments	 using	 13C	 and	 15N	 labeled	 versions	 of	 the	
three	most	consumed	substrates	(glucose,	asparagine	and	serine),	to	explore	with	more	
detail	 the	 intracellular	 metabolism	 of	 GS-CHO	 cells	 in	 control	 and	 butyrate-treated	
cultures.	 The	 incorporation	 of	 13C/15N	 from	 each	 substrate	 into	 intracellular	
metabolites,	 including	 amino	 acids	 and	 intermediates	 from	 glycolysis,	 pentose	
phosphate	pathways	and	TCA	cycle,	was	 followed	over	 time	by	GC-MS	and	LC-MS.	 In	
chapter	4,	modulations	of	asparagine	and	serine	availability	in	cell	culture	media	were	
performed,	 in	 order	 to	 study	 their	 essentiality	 and	 effect	 on	 cell	 physiology,	 namely	
their	 inter-relationships	 in	 nitrogen	 and	 carbon	 metabolism,	 biosynthesis	 and	 the	
impact	on	culture	performance.	Furthermore,	we	used	13C	labeled	pyruvate	and	GC-MS	




that	 allowed	 identification	 of	 potential	 targets	 for	 minimizing	 overflow	 metabolism,	
reducing	 the	 diversion	 of	 resources	 to	 by-product	 accumulation,	 or	minimising	 their	
impact	on	recombinant	protein	production.	Also,	it	allowed	the	association	of	PPP	and	
ME	 activities,	 important	 sources	 of	NADPH,	with	 a	 high	 productive	 phenotype	 in	GS-
CHO	 cells.	 These	 biological	markers	 can	 represent	 an	 opportunity	 for	 future	 process	
and	 cell	 engineering	 efforts	 aiming	 towards	 the	 improvement	 of	 biopharmaceuticals	
production.		
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Abstract 
	
Chinese	 hamster	 ovary	 (CHO)	 cells	 are	 preferred	 hosts	 for	 the	 production	 of	
recombinant	 biopharmaceuticals.	 Efforts	 to	 optimize	 these	 bioprocesses	 have	 largely	




(1H-NMR)	 to	 analyze	 the	 supernatants	 of	 glutamine-synthetase	 (GS)-CHO	 cell	 clones	
expressing	variable	amounts	of	an	IgG4	under	control	and	butyrate-treated	conditions.	
Exometabolomic	 data	was	 contextualized	 in	 a	 detailed	 network	 of	 117	 reactions	 and	
the	cellular	 fluxomes	estimated	through	metabolic	 flux	analysis	(MFA).	This	approach	
allowed	 comparing	 metabolic	 activity	 across	 different	 clones,	 growth	 phases	 and	
culture	conditions,	in	particular	the	efficiency	pertaining	to	carbon	lost	to	glycerol	and	




































Mammalian	 cell	 lines	 are	 the	 preferred	 hosts	 for	 industrial	 production	 of	 complex	
protein	 therapeutics	 (Wurm,	 2004).	 In	 particular,	 Chinese	hamster	 ovary	 (CHO)	 cells	
are	 often	 used	 to	 express,	 among	 other	 products,	 monoclonal	 antibodies	 (mAbs)	 to	
treat	 cancer	 and	 immunological	 disorders.	 Although	 mammalian	 cell	 culture	 is	
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systems	 as	 they	 are	 closely	 connected	 with	 the	 growth	 and	 productive	 phenotypes.	
Metabolic	flux	analysis	(MFA)	is	such	a	tool	based	on	the	principle	of	mass	conservation	
within	 a	 stoichiometric	 network	 of	 cellular	 metabolism,	 allowing	 the	 estimation	 of	
intracellular	 fluxes	 under	 assumed	metabolic	 steady	 state	 given	measurable	 rates	 of	
nutrient	consumption	and	byproduct	accumulation	(Stephanopoulos	et	al.,	1998).	This	
technique	 has	 been	 applied	 for	 over	 a	 decade	 to	 several	 CHO	 cell	 lines	 to	 identify	
bottlenecks	 in	primary	and	secondary	metabolic	pathways	and	 to	gain	 insights	about	
the	 balance	 between	 catabolic	 and	 anabolic	 processes	 (reviewed	 in	 Ahn	 and	
Antoniewicz,	2012).	Central	to	these	works	has	been	the	study	of	overflow	metabolism	
that	 leads	 to	 by-product	 accumulation	 such	 as	 lactate,	 ammonia	 and	 alanine,	 which	
negatively	 impacts	 cell	 growth	and	 recombinant	product	 formation	 through	 resource	
waste	and	toxicity	build-up.	The	information	generated	has	guided	the	development	of	
bioprocess	 strategies	 to	 minimize	 these	 limitations;	 for	 instance,	 Altamirano	 et	 al.	
(2000,	 2004)	 have	 studied	 media	 design	 and	 fed-batch	 strategies	 involving	 the	
substitution	 of	 the	 main	 carbon	 (glucose)	 and	 nitrogen	 (glutamine)	 sources	 by	 the	
more	 slowly	 metabolized	 compounds	 galactose	 and	 glutamate,	 respectively.	 Also,	
genetic	engineering	efforts	have	targeted	 lower	 lactate	production	through	enzymatic	
manipulation	 (Fogolín	 et	 al.,	 2004;	Kim	and	Lee,	2007;	Zhou	et	 al.,	 2011).	During	 the	
last	 few	 years,	 13C-MFA	 techniques	 using	 isotopic	 tracers	 have	 been	 useful	 to	
distinguish	 reversible	 and	 parallel	 reaction	 fluxes,	 in	 particular	 elucidating	 the	
diversion	 of	 glucose	 to	 the	 pentose	 phosphate	 pathway	 (PPP)	 and	 the	 activity	 of	




(TCA)	 cycle	 (Ahn	 and	 Antoniewicz,	 2011,	 2013;	 Goudar	 et	 al.,	 2010;	 Sengupta	 et	 al.,	
2011;	Templeton	et	al.,	2013).	However,	despite	the	collective	knowledge,	we	are	still	
lacking	 a	 comprehensive	 understanding	 of	 how	 mammalian	 cell	 metabolism	 is	
regulated	 under	 variable	 bioprocess	 conditions,	 limiting	 rational	 optimization	 efforts	
(Ahn	and	Antoniewicz,	2012).	
With	the	advent	of	systems	biotechnology	tools	for	generation	and	contextualization	of	
“omic”	cellular	data,	 together	with	high-throughput	culture	 technologies,	 the	quantity	
and	 quality	 attributes	 of	 mammalian	 cell	 bioprocess	 performance	 are	 starting	 to	 be	
elucidated	 (Carinhas	 et	 al.,	 2012;	 Griffin	 et	 al.,	 2007).	 Noteworthy,	 the	 genome	
sequence	of	the	CHO-K1	cell	line	has	been	recently	published	(Xu	et	al.,	2011),	opening	
the	way	 for	 reliable	 genome-based	 omic	 analyses	 and	 large-scale	metabolic	 network	
reconstruction.	 In	parallel,	 advances	 in	metabolomics	 tools	have	materialized	 in	 their	
application	to	mammalian	cell	cultures,	significantly	increasing	in	recent	years	to	study	
CHO	 cells.	 Examples	 include	 the	 analysis	 of	 growth	 characteristics	 using	 different	
culture	 media	 (Dietmair	 et	 al.,	 2012),	 metabolic	 engineering	 of	 TCA	 cycle	 activity	
resulting	 in	 growth	 improvement	 (Chong	 et	 al.,	 2010),	 characterization	 of	 CHO	 cells	
with	 high	mAb	 productivities	 (Chong	 et	 al.,	 2012),	 understanding	 the	 production-to-






exometabolome	 of	 glutamine	 synthetase	 (GS)-CHO	 cells	 along	 culture	 time,	 which	 is	
then	used	 to	 identify	 an	extended	metabolic	network	 through	MFA.	Two	GS-CHO	cell	
clones	with	different	growth	and	production	phenotypes	are	studied	under	control	and	
butyrate-treated	 conditions.	 Comparatively	 to	 other	mammalian	 expression	 systems,	
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GS-CHO	cells	are	poorly	characterized,	and	the	metabolic	comparison	of	different	CHO	
producer	 clones	 is	 limited	 (Dean	 and	 Reddy,	 2013;	 Chong	 et	 al.,	 2012).	 In	 addition,	
butyrate	treatment	has	been	investigated	before	on	the	transcriptomic	and	proteomic	
levels	(Gatti	et	al.,	2007;	Kantardjieff	et	al.,	2010;	Yee	et	al.,	2008),	but	not	on	the	global	
exometabolome	 and	 fluxome	 levels.	 It	 is	 a	 histone	 deacetylase	 inhibitor	 with	 a	
pronounced	effect	on	specific	productivity	of	recombinant	proteins	in	mammalian	cell	
expression	 systems	 (Jiang	 and	 Sharfstein,	 2008),	 being	 classically	 used	 both	 in	
fundamental	 research	 as	 well	 as	 for	 bioproduction.	 Of	 note,	 a	 recent	 breakthrough	
study	 has	 shown	 that	 lysine	 acetylation	 is	 a	 post-translational	 modification	 in	 most	
enzymes	 of	 the	 central	 metabolism	 (Zhao	 et	 al.,	 2010)	 and	 is	 able	 to	 increase	 or	
decrease	 the	 flux	 through	 the	 respective	 reactions	 up	 to	 twofold	 (Wang	 et	 al.,	 2010;	
Zhao	 et	 al.,	 2010).	 Thus,	 investigating	 the	 impact	 of	 butyrate	 treatment	 on	 the	




CHO	 cell	 clones	 generated	 by	 stable	 transfection	 of	 the	 CHOK1SV	 cell	 line	 with	 a	
construct	 containing	 GS	 and	 the	 light	 and	 heavy	 chains	 of	 an	 IgG4	mAb,	were	 kindly	
provided	by	Lonza	Biologics	(UK).	Cells	were	maintained	in	CDCHO	chemically	defined	
medium	 (Cat.	 No.	 10743-029,	 Gibco,	 Life	 Technologies,	 Carlsbad,	 CA)	 supplemented	
with	25	µM	methionine	sulphoximine	(Cat.	No.	M5379,	Sigma-Aldrich,	St.	Louis,	MO),	in	
125	mL	 shake	 flasks	with	25	mL	of	 culture	 volume	and	 sub-cultured	 every	3–4	days	
with	 a	 seeding	 density	 of	 0.4	 x	 106	 cell/mL.	 All	 cultures	 were	 kept	 in	 a	 humidified	
incubator	controlled	at	37°C	and	7%	CO2	with	shaking	at	130	rpm.	
In	this	work,	three	sets	of	four	cultures	each	were	performed	using	two	CHO	cell	clones	
(a	 lower	 and	 a	 higher	 producer,	 respectively	 LP	 and	 HP)	with	 and	without	 butyrate	
treatment	 (0.75	mM	sodium	butyrate	 (Cat.	No.	8175000100,	Merck,	Germany)	added	















stationary	 growth.	 For	 each	 condition,	 duplicate	 cell	 pellets	 of	 at	 least	 140	 x106	 cells	




Accumulation	 of	 IgG	 in	 the	 supernatant	was	monitored	 using	 sandwich	 ELISA	 assay.	
Briefly,	 	Nunc	Maxisorp	96-well	plates	(Cat.	No.	437842,	Thermo	Scientific,	USA)	were	
coated	 with	 a	 goat	 anti-human	 IgG,	 Fcγ	 specific	 (Cat.	 No.	 109-006-098,	 Jackson	
Immunoresearch	Labs,	USA)	at	a	concentration	of	2	µg/L	in	carbonate	buffer.	Blocking	
was	 performed	 with	 0.5	 %	 casein	 in	 carbonate	 buffer.	 Solutions	 with	 known	
concentrations	of	antibody	were	included	on	each	plate	for	calibration.	Bound	antibody	
was	 detected	 using	 goat	 anti-human	 IgG	 (Fab	 specific)-peroxidase	 antibody	 (Cat.	 No.	
A0293,	Sigma-Aldrich,	USA).	The	complex	was	visualized	with	TMB	substrate	(Cat.	No.	
00-2023,	 Invitrogen,	 Life	 Technologies,	 USA)	while	 2.5	M	 sulphuric	 acid	was	 used	 as	
stop	solution.	Colour	development	was	measured	at	450	nm.		
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2.2.4 Total	protein	quantification	
The	total	protein	content	in	supernatant	samples	along	culture	was	quantified	with	the	
Coomassie	 Plus	 (Bradford)	 Protein	 Assay	 reagent	 (Cat.	 No.	 23238,	 Pierce,	 Thermo	
Scientific,	USA)	using	Bovine	Gamma	Globulin	(Cat.	No.	23212,	Thermo	Scientific,	USA)	
as	 the	 protein	 reference	 standard.	 Briefly,	 10	 μL	 of	 each	 sample	 were	 mixed	 in	 a	




in	 order	 to	 	 verify	 the	 quality	 of	 secreted	 IgG.	 Supernatant	 samples	 from	HP	 and	 LP	
cultures	 were	 run	 on	 1-mm	 NuPAGE	 Novex	 BisTris	 gels	 (Cat.	 No.	 NP0322BOX,	
Invitrogen,	 Life	 Technologies)	 using	 purified	 mAb	 as	 reference.	 Gels	 were	 either	
revealed	with	Instant	blue	(Cat.	No.	ISB1L,	Expedeon,	Harston,	Cambridgeshire,	UK)	or	
electrically	 transferred	 to	 a	 nitrocellulose	membrane	 (Cat.	 No.	 RPN203E,	 Amersham,	
GE	 HealthCare,	 Fairfield,	 CT).	 Immunochemical	 staining	 was	 carried	 out	 with	 goat	
antihuman	IgG,	Fcγ	specific	(see	above)	at	2	μg/L	during	2	h	at	room	temperature.	The	
blot	was	developed	using	the	ECL	Prime	Western	Blotting	Detection	Reagent	(Cat.	No.	
RPN2232,	Amersham,	GE	HealthCare)	and	exposed	 to	X-ray	 light	after	1	h	 incubation	
with	 ECL	 anti-mouse	 IgG,	 peroxidase-linked	 whole	 antibody	 from	 sheep	 (NA931,	
Amersham,	GE	Healthcare)	at	a	1:5.000	dilution	at	room	temperature.	
2.2.6 Exometabolome	analysis	
1H-NMR	was	 performed	 in	 a	 500	MHz	 Avance	 spectrometer	 (Bruker,	 USA)	 equipped	
with	 a	 5	mm	QXI	 inversed	 probe.	 Spectra	were	 acquired	 using	 a	NOESY-based	 pulse	
sequence	with	water	presaturation,	performing	256	scans	with	4	s	acquisition	time,	1	s	
relaxation	delay	 and	100	ms	mixing	 time	 at	 25	 °C.	DSS-d6	 (613150,	 Isotec,	USA)	was	
used	 as	 internal	 standard	 for	 metabolite	 quantification	 in	 all	 samples.	 In	 order	 to	
maintain	a	constant	pH	between	samples,	these	were	mixed	with	phosphate	buffer	(pH	
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7.4)	 prepared	 in	 D2O	 (151882,	 Aldrich,	 Canada)	 at	 a	 2:1	 ratio.	 Before	 spectra	
acquisition,	 the	 spectrometer	 was	 calibrated	 by	 determining	 the	 90°	 pulse	 and	 the	
water	chemical	shift	centre	of	each	sample.		
Each	spectrum	was	phased,	baseline	corrected	and	integrated	using	the	Chenomx	NMR	
Suite	 7.1	 (Chenomx,	 Canada).	 Most	 metabolites	 are	 defined	 by	 several	 clusters	 at	
different	 chemical	 shifts,	 which	 in	 some	 cases	 may	 overlap	 or	 be	 affected	 by	 the	




limit	below	180	μM	and	an	average	error	of	3	%.	Chemical	 shifts	of	 clusters	used	 for	
quantification,	correction	factors,	errors	and	limits	are	available	in	Duarte	et	al.	(2013).		
Ammonia	was	quantified	using	an	enzymatic	kit	(Cat.	No.	AK00091,	NZYTech,	Portugal),	
based	 on	 the	measurement	 at	 340	 nm	 of	 the	 amount	 of	 NADP+	 formed	 through	 the	
action	of	glutamate	dehydrogenase	(GIDH).	
2.2.7 Metabolic	network	
A	 network	 of	 central	 metabolic	 pathways	 of	 CHO	 cells	 was	 initially	 assembled	 from	
published	 models	 (Quek	 et	 al.,	 2010;	 Sengupta	 et	 al.,	 2011;	 Zamorano	 et	 al.,	 2010).	
Based	 on	 our	 1H-NMR	 exometabolomic	 analysis,	 it	 was	 further	 complemented	 with	
reactions	 taken	 from	 basic	 biochemistry	 textbooks	 to	 account	 for	 the	metabolism	 of	
compounds	not	previously	considered	(see	Results	section),	therefore	filling	the	gaps	in	
our	comprehensive	model.	The	extended	network	is	composed	of	the	main	reactions	of	
central	 metabolism	 of	 cultured	 animal	 cells,	 namely	 glycolysis,	 pentose	 phosphate	
pathway	 (PPP),	 TCA	 cycle,	 glutaminolysis,	 amino	 acids	 metabolism,	 by-product	
formation	 and	 extracellular	 transport	 fluxes.	 Following	 are	 some	 assumptions	 and	
simplifications	 made:	 subcellular	 compartmentalization	 was	 not	 considered;	 PPP	 is	
defined	 by	 growth	 requirements	 only,	 not	 reconnecting	 back	 to	 glycolysis;	 pyruvate	
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et	 al.,	 2005).	 The	 amino	 acid	 composition	 of	 CHO	 cellular	 proteins	 was	 recently	
analysed	and	used	in	this	work	(Selvarasu	et	al.,	2012).	Measured	cellular	dry	weights	






The	 metabolic	 model	 developed	 considers	 117	 reactions	 (including	 extracellular	
transport	 fluxes	 and	 the	 specific	 growth	 rate	 of	 cells)	 and	 83	 balanced	 metabolites.	
From	 our	 experimental	 data,	 45	 rates	 were	 determined	 (35	 exometabolites,	 specific	
productivity	 and	 growth	 rate,	 plus	 8	 intracellular	 fluxes	 assumed	 to	 be	 equal	 to	 the	
corresponding	 measured	 extracellular	 rates;	 see	 Appendix).	 The	 rank	 of	 the	
stoichiometric	matrix	 is	82,	 resulting	 in	an	over	determined,	 redundant	 system	of	10	
degrees	 of	 freedom	 (82-(117-45)).	 To	 solve	 this	 system,	 a	 weighted-least	 squares	
estimate	 for	 the	 flux	 distribution	 was	 calculated	 under	 the	 pseudo-steady	 state	
assumption	 (Stephanopoulos	 et	 al.,	 1998).	 In	 addition,	 adjusted	 flux	 measurements	
were	used	to	calculate	a	consistency	index,	h,	as	defined	in	Wang	and	Stephanopoulos	
(1983).	Comparison	of	h	with	the	χ2	test	function	allowed	evaluating	the	consistency	of	
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2.3 Results	and	Discussion	
2.3.1 Culture	behaviour	and	exometabolomic	trends	of	GS-CHO	cells	
Three	 culture	 sets	 were	 performed	 using	 LP	 and	 HP	 cell	 clones,	 with	 and	 without	
butyrate	 treatment	 as	 described	 in	 the	 Materials	 and	 Methods	 Section.	 Figure	 2.2	
shows	typical	growth	and	production	profiles	(corresponding	to	culture	set	I).	The	LP	
reaches	 higher	 cell	 densities	 in	 less	 time	 than	 the	 HP,	 which	 had	 a	 more	 prolonged	
stationary	phase	(Fig.	2.2A).	It	can	be	observed	that	the	differences	in	growth	profiles	
between	 clones	 are	 accompanied	 by	 a	 larger	 IgG	 production	 capacity	 in	 the	HP	 (Fig.	
2.2B),	 resulting	 in	average	specific	productivities	around	2.5-fold	higher	 for	 the	 three	
culture	sets	(Fig.	2.2C).	As	expected,	butyrate	 treatment	negatively	 impacts	growth	 in	
both	clones,	capping	peak	cell	densities	and	inducing	earlier	entry	into	stationary	phase,	
but	sustains	IgG4	productivity,	which	increases	on	average	by	1.5-	and	3-fold	on	a	per	
cell	 basis	 during	 the	 exponential	 and	 stationary	 growth	 phases,	 respectively.	
Interestingly,	 the	 concentration	 of	 butyrate	 in	 the	 supernatant	 does	 not	 change	
significantly	over	time	in	butyrate-treated	cultures,	while	there	is	a	small	accumulation	
of	 butyrate	 in	 control	 cultures	 (Fig.	 2.3).	 Several	 studies	 have	 shown	 that	 butyrate	
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Specific	 IgG	productivities	and	 indicated	ratios	determined	as	 the	average	 from	culture	sets	 I,	 II,	 and	 III.	
Depending	 on	 the	 culture,	 metabolic	 phases	 were	 divided	 as	 follows:	 exponential	 from	 24	 to	 72/96	 h,	
stationary	from	72/96	to	144/168	h.	The	HP/LP	specific	productivity	ratio	pools	together	both	phases	of	
control	 and	 butyrate	 treated	 cultures	 since	 no	 significant	 differences	 in	 this	 ratio	 could	 be	 observed	
between	them.	Likewise,	the	calculation	of	the	remaining	ratios	pools	together	both	clones.	
Glycerol	 accumulated	 over	 culture	 time,	 branching	 from	 glycolysis	 at	 the	
dihydroxyacetone-phosphate	 (DHAP)	 node	 involving	 NADH	 oxidation	 (Fig.	 2.5F),	
whereas	acetate	 (from	acetyl-CoA)	starts	 to	build	up	after	 the	onset	of	 the	stationary	
phase	(Fig.	2.5G).	The	profile	of	formate	correlates	well	with	that	of	glycine	(Fig.	2.5H	
and	I),	both	metabolites	coming	from	the	catabolism	of	serine,	which	is	the	main	donor	
for	 1C	 units	 metabolism	 (Narkewicz	 et	 al.,	 1996).	 TCA	 cycle	 intermediates	 such	 as	
citrate,	fumarate,	malate	and	succinate	are	also	secreted	to	the	supernatant	(Fig.	2.5J–
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M)	as	previously	 reported	 (Chong	et	 al.,	 2010;	Dietmair	et	 al.,	 2012;	Ma	et	 al.,	 2009).	




phase	 (Table	 2.1).	 Only	 modest	 differences	 could	 be	 observed	 between	 clones,	
displaying	 qualitatively	 similar	 metabolite	 profiles	 and	 generally	 close	 specific	
metabolic	 rates.	 On	 the	 other	 hand,	 these	 were	 significantly	 affected	 by	 butyrate	
treatment,	 largely	due	 to	 the	negative	 effect	on	 cell	 growth,	 resulting	 in	 substantially	
higher	metabolic	rates	during	the	stationary	phase	(Table	2.1).	
	
Figure	 2.3	 Extracellular	 butyrate	 concentration	 profiles	 under	 control	 and	 treated	 (But)	 conditions	 for	
culture	set	I.	Sodium	butyrate	was	added	24h	after	inoculation	at	a	concentration	of	0.75	mM.	




led	 to	 a	 small	 increment	 in	maximum	 cell	 density	 in	 the	HP	 and	 prolongation	 of	 the	
stationary	phase	in	both	clones,	but	was	not	accompanied	by	any	significant	differences	
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in	 final	mAb	 titers	 (data	 not	 shown).	A	 shift	 from	 lactate	 production	 to	 consumption	
(between	48	and	72	h)	occurred	before	cells	had	reached	their	maximum	density	and	
any	of	the	analyzed	nutrients	was	depleted	(Fig.	2.5A).	This	metabolic	switch	has	been	
reported	 to	 occur	 upon	 depletion	 of	 glucose	 (Martínez	 et	 al.,	 2013)	 or	 during	 later	
growth	and	stationary	phases	of	CHO	(Dean	and	Reddy,	2013;	Ma	et	al.,	2009)	as	well	
as	NS0	cells	(Khoo	and	Al-Rubeai,	2009;	Ma	et	al.,	2009;	Mulukutla	et	al.,	2012),	and	is	
related	with	 decreased	 glucose	 consumption	 and	 balancing	 of	 the	 NADH/NAD+	 ratio	
(Mulukutla	et	al.,	2010,	2012).	Interestingly,	our	results	confirm	a	previous	observation	
by	Ma	et	al.	 (2009)	 that	 the	sum	of	 the	specific	glucose	and	 lactate	metabolic	rates	 is	
approximately	 constant	 across	 exponential	 and	 stationary	phases;	 the	only	 exception	
was	 the	 case	of	butyrate-treated	HP	cultures,	 owing	 to	a	much	 larger	average	 lactate	
production	 rate	 during	 exponential	 growth.	 A	 switch	 from	 alanine	 secretion	 to	
consumption	 in	 control	 cultures	 was	 also	 observed	 concurrently	 with	 aspartate	
exhaustion,	 closely	 following	 asparagine	 depletion	 (Figs.	 2.4D,	 F	 and	 2.5C).	 This	
phenomenon	 is	 consistent	 across	 all	 cultures	 and	 is	 delayed	 in	 culture	 set	 III	 where	
both	 amino	 acids	 are	 supplemented	 at	 72	 h.	 On	 average,	 this	 resulted	 in	 a	 slightly	
negative	 specific	 alanine	 rate	 for	 the	 LP	 (consumption),	 which	 remained	 slightly	
positive	 for	 the	HP	(Table	2.1).	 In	contrast,	butyrate	 treatment	kept	alanine	secretion	
high	 during	 the	 entire	 culture	 time	 as	 aspartate	 depletion	 does	 not	 occur	 before	
viability	 starts	 to	 decrease.	 To	 our	 knowledge,	 these	 modulations	 in	 alanine	
metabolism	have	not	been	reported	before.	
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and	 stationary	 growth	 phases	 (Fig.	 2.2).	 Rates	 of	 metabolite	 consumption	 and	
production	(Table	2.1),	 together	with	specific	growth	and	IgG4	production	rates,	were	
used	 as	 constraints	 for	 MFA.	 Importantly,	 metabolic	 requirements	 for	 biomass	
synthesis	were	 adjusted	 to	 the	measured	 cell	 dry	weights	measured:	 on	 average	271	
pg/cell	 for	 control	 and	 butyrate-treated	 cultures	 during	 exponential	 growth	 and	 a	
higher	 value	 of	 368	 pg/cell	 for	 butyrate-treated	 cultures	 during	 stationary	 phase.	
Importantly,	 comparisons	 of	 specific	 metabolic	 fluxes,	 in	 particular	 specific	
productivity,	 are	not	 qualitatively	 altered	when	 adjusting	with	 the	measured	 cell	 dry	
weights.		
To	 our	 knowledge,	 this	model	 contains	 the	 largest	 number	 of	metabolic	 reactions	 in	
studies	 of	 CHO	 cells	 not	 involving	 the	 definition	 of	 an	 objective	 function	 for	 flux	
balancing	 (see	review	 in	Ahn	and	Antoniewicz,	2012).	As	a	 future	endeavor,	 the	 time	
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profiles	 of	 exometabolomic	 data	 could	 further	 be	 used	 to	 establish	 a	 kinetic	 model	
combined	to	MFA	allowing	capturing	the	dynamics	of	metabolic	behavior	(Niklas	et	al.,	
2011;	 Nolan	 and	 Lee,	 2011).	 The	 quality	 of	 the	 metabolic	 model	 and	 conclusions	
derived	 thereof	 requires	 that	 no	 faulty	 assumptions	 in	 the	 biochemistry	 or	 gross	
measurement	 errors	 are	 present.	 To	 evaluate	 this,	 the	 consistency	 index	 h	 was	
calculated	 and	 compared	 with	 the	 χ2	 value	 at	 a	 95%	 confidence	 interval	 for	 each	
metabolic	 phase	 (see	 Materials	 and	 Methods	 Section).	 Furthermore,	 carbon	 (C)	 and	
nitrogen	 (N)	 balances	 were	 calculated	 based	 on	 the	 transport	 flux	 data	 and	 MFA	
estimated	 CO2	 production	 rates.	 A	 preliminary	 analysis	 showed	 that	 acceptable	 N	
balance	 results	 could	 only	 be	 obtained	 when	 considering	 the	 measurement	 of	 total	
extracellular	 protein	 content	 instead	 of	 ELISA-based	 IgG	 quantification.	 Further	
analysis	 through	 SDS–PAGE	 and	 Western	 blotting	 revealed	 that	 total	 protein	 was	
composed	 mostly	 of	 IgG4,	 a	 portion	 of	 which	 was	 not	 correctly	 assembled	 into	 a	
quaternary	structure	(data	not	shown).	Total	protein	measurements	were	hence	used	
in	 all	 MFA	 calculations	 considering	 the	 IgG4	 composition	 detailed	 in	 Appendix	 1.	
Importantly,	 these	 measurements	 yielded	 similar	 ratios	 of	 specific	 productivity	
between	 culture	 phases	 and	 between	 control	 and	 butyrate-treated	 cultures;	 only	 the	
ratio	between	HP	and	LP	was	smaller	(around	1.5)	when	compared	to	that	calculated	
based	 on	 ELISA	 results	 (around	 2.5	 as	 stated	 before).	 This	 may	 suggest	 the	 larger	
portion	of	productivity	difference	between	clones	 is	 associated	with	 correct	antibody	
chain	assembly.		
On	average,	the	C	balance	closes	at	93%	and	the	N	balance	at	86%,	whereas	for	19	out	
of	 24	 scenarios	 the	 h	 value	 is	 lower	 than	 the	χ2	 threshold	 (Table	 2.2).	 These	 results	
indicate	 that	 the	 network	 is	 well	 posed	 and	 that	 no	 gross	 measurement	 errors	 are	
being	propagated	 in	 the	estimated	 fluxes.	Also,	 it	 suggests	 that	our	assessment	of	 the	
exometabolome	 is	 reasonably	 comprehensive.	 The	 five	 phases	 where	 acceptable	
consistencies	were	not	achieved	included	control	and	butyrate-treated	cultures	during	
either	 exponential	 or	 stationary	 growth,	 not	 revealing	 biases	 in	 the	 complete	 set	 of	
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Table	 2.1	Average	 specific	 metabolic	 secretion	 and	 consumption	 rates	 for	 HP	 and	 LP	 cultures	 under	
control	and	butyrate-treated	conditions.	
	
HP	 HP	But	 LP	 LP	But	
	 Exp.	 Sta.	 Exp.	 Sta.	 Exp.	 Sta.	 Exp.	 Sta.	
Aspartate	 -6.82	 -2.49	 -3.70	 -8.70	 -5.37	 -2.70	 -4.76	 -5.63	
Glycine	 1.89	 2.18	 4.19	 1.96	 1.99	 3.09	 2.42	 2.81	
Serine	 -11.67	 -2.64	 -11.02	 -10.60	 -9.69	 -2.91	 -13.35	 -5.04	
Glutamate	 -3.36	 -1.64	 -6.01	 -2.80	 -3.59	 -0.87	 -3.63	 -1.72	
Tyrosine	 -1.43	 -0.47	 -1.65	 -1.57	 -1.21	 -0.39	 -1.56	 -0.90	
Alanine	 6.43	 2.69	 12.59	 16.71	 4.28	 -0.47	 8.22	 8.50	
Arginine	 -2.99	 -1.31	 -3.92	 -2.08	 -3.13	 -0.38	 -4.71	 -0.74	
Asparagine	 -20.25	 -2.09	 -25.35	 -16.44	 -16.09	 -2.34	 -24.64	 -9.05	
Glutamine	 0.75	 -0.33	 2.21	 0.24	 0.09	 0.13	 0.85	 0.38	
Histidine	 -1.75	 -0.18	 -0.88	 -1.22	 -1.01	 -0.26	 -1.62	 -0.46	
isoleucine	 -3.20	 -1.25	 -3.43	 -3.29	 -3.34	 -1.12	 -3.54	 -2.58	
Leucine	 -5.47	 -2.26	 -6.12	 -5.47	 -5.29	 -2.02	 -6.51	 -4.56	
Lysine	 -3.41	 -1.34	 -5.68	 -3.45	 -4.16	 -0.77	 -4.30	 -3.13	
Methionine	 -1.30	 -0.21	 -1.23	 -1.10	 -1.33	 -0.19	 -1.76	 -0.70	
Phenylalanine		 -1.76	 -0.44	 -2.15	 -1.41	 -1.35	 -0.33	 -1.96	 -1.00	
Proline	 -3.15	 -1.14	 -2.59	 -2.39	 -3.69	 -0.80	 -5.72	 -1.22	
Threonine	 -4.15	 -1.41	 -10.18	 -2.56	 -1.48	 -0.80	 -4.42	 -1.15	
Tryptophan	 -0.86	 -0.45	 -0.97	 -0.92	 -0.87	 -0.24	 -0.94	 -0.51	
Valine	 -4.09	 -1.15	 -4.16	 -3.72	 -3.34	 -1.15	 -4.68	 -2.20	
Choline	 -0.84	 -0.41	 -1.06	 -0.88	 -0.88	 -0.44	 -1.09	 -0.64	
Ammonia	 11.86	 4.55	 14.69	 3.89	 6.01	 5.05	 12.49	 4.52	
Citrate	 0.60	 0.46	 1.32	 1.08	 0.53	 0.47	 0.75	 0.92	
Fumarate	 0.05	 0.02	 0.04	 0.07	 0.03	 0.02	 0.03	 0.06	
Pyruvate	 -2.92	 -0.92	 -3.35	 -1.79	 -2.32	 -0.78	 -2.76	 -1.04	
Succinate	 0.11	 0.04	 0.07	 0.11	 0.08	 0.05	 0.07	 0.10	
Malate	 0.45	 0.24	 0.30	 1.03	 0.32	 0.18	 0.54	 0.62	
Glycerol	 4.10	 5.14	 4.70	 9.59	 4.17	 4.64	 4.03	 8.12	
Phosphocoline	 0.09	 0.08	 0.11	 0.21	 0.08	 0.11	 0.14	 0.23	
Glycero-3-phosphocholine	 0.19	 0.22	 0.24	 0.25	 0.18	 0.27	 0.10	 0.26	
Formate	 3.41	 1.84	 5.75	 3.20	 3.15	 1.93	 3.90	 3.23	
Acetate	 0.02	 2.08	 0.10	 0.75	 0.02	 1.35	 -0.23	 1.18	
Isobutyrate	 0.46	 0.46	 0.57	 0.96	 0.53	 0.59	 0.47	 0.95	
Isovalerate	 1.28	 1.56	 1.60	 2.29	 1.38	 1.95	 1.32	 2.63	
Glucose	 -73.46	 -27.87	 -77.80	 -72.84	 -83.92	 -22.28	 -106.65	 -55.07	
Lactate	 36.75	 -12.16	 71.24	 -14.57	 36.42	 -15.74	 33.24	 -14.30	
Average	 rates	 were	 calculated	 from	 the	 three	 culture	 sets	 performed,	 and	 are	 expressed	 in	
nmol/106cells/h.	 Culture	 phases	were	 divided	 as	 follows:	 exponential	 from	24	 h	 to	 72/96	 h,	 stationary	
from	72/96	h	to	144/168	h,	depending	on	the	culture.	A	negative	sign	indicates	consumption.	





Figure	 2.5	 Extracellular	 concentration	 profiles	 of	 main	 secreted	 metabolites	 quantified	 in	 the	
exometabolome	of	culture	set	I,	including	control	and	butyrate-treated	(But)	cultures	of	HP	and	LP	clones.	
Glyc3PC,	glycerol-3-phosphocholine.	
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Table	 2.2	Overview	of	metabolic	 phases	 studied.	 Carbon	 (C)	 and	nitrogen	 (N)	balances	 calculated	 from	
transport	flux	data	and	MFA	estimated	CO2	production	rates.	To	evaluate	metabolic	consistency,	the	cut-off	
χ2	value	at	95%	confidence	level	for	10	degrees	of	freedom	is	18.307.	*Outlier	with	low	C	and	N	balance.	












































In	mammalian	 cells,	 an	 important	 determinant	 for	 glucose	 carbon	 loss	 to	 by-product	
formation	 is	 the	 balancing	 of	 the	 redox	 state	 between	 cytosol	 and	 mitochondria	
(Mulukutla	et	al.,	2010).	NADH	produced	in	glycolysis	must	be	regenerated	to	NAD+	by	
transferring	of	reduced	equivalents	 to	mitochondria	via	 the	malate–aspartate	and	the	
glycerol-3-phosphate	 shuttle	 systems.	 During	 exponential	 growth,	 excess	 NADH	
produced	 that	 cannot	 be	 effectively	 transferred	 leads	 to	 high	 rates	 of	 lactate	
accumulation.	 Overall,	 the	 GS-CHO	 cell	 clones	 analyzed	 under	 standard	 culture	
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conditions	 displayed	 higher	 metabolic	 efficiency	 at	 the	 glycolysis–TCA	 cycle	 bridge	
than	previously	 reported	 for	other	CHO/mammalian	cell	 lines	 (Ahn	and	Antoniewicz,	
2011,	2012).	As	an	average	for	both	clones,	26%	of	the	pyruvate	formed	was	channeled	
to	 lactate	 formation	 (Fig.	 2.6).	 In	 addition,	 a	 smaller	 5%	 diversion	 of	 carbon	 from	
glycolysis	 to	 glycerol	 accumulation	 during	 the	 exponential	 phase	 could	 be	 observed.	
Overall,	the	metabolic	efficiency	pertaining	to	these	two	key	regulatory	steps	involving	




pyruvate	 formed),	 which	 resulted	 in	 an	 increase	 to	 100%	 (100%-24%+24%)	 in	 the	
efficiency	 of	 carbon	 flow	 associated	 with	 the	 same	 two	 metabolic	 nodes,	 and	 an	
increment	 to	92%	 in	 the	percentage	of	pyruvate	 channeled	 to	AcCoA	 formation.	This	
divergent	 behavior	 suggests	 that	 increased	 glycerol	 accumulation	 fulfills	 other	
homeostatic	 roles	 such	 as	 regulation	of	 cellular	 osmolarity;	 for	 instance,	 Sellick	 et	 al.	
(2011)	 detected	 accumulation	 of	 glycerol	 and	 sorbitol	 in	 a	 GS-CHO	 batch	 bioreactor.	
The	 modulations	 described	 above	 were	 accompanied	 by	 a	 general	 downtrend	 of	
metabolic	 flow	 into	 the	 stationary	 growth	 phase,	 as	 a	 result	 of	 lower	 nutrient	




time,	 carboxylates	 such	as	 citrate,	 fumarate,	malate	and	succinate	were	 secreted	 (see	
Fig.	2.5J–M),	representing	approximately	the	same	proportion	to	TCA	cycle	flux	in	both	
phases,	 possibly	 indicating	 it	 is	 operating	 close	 to	 maximum	 enzymatic	 capacity	
throughout	 culture	 time	 (Chong	 et	 al.,	 2010).	 It	 is	 important	 to	 note	 that	 the	 results	
presented	 herein	 are	 limited	 by	 the	 unavailability	 of	 labeling	 data	 and	 thus	 cannot	
discern	 pathways	 such	 as	 the	 flux	 through	 PC	 at	 the	 glycolysis–TCA	 cycle	 bridge	
(parallel	 to	 PDH)	 and	 the	 recycling	 of	 pentose–phosphates	 back	 to	 glycolysis	 (PPP	
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being	determined	by	growth	requirements	alone).	For	instance,	Sengupta	et	al.	(2011)	
have	 analyzed	metabolic	 efficiency	 at	 the	 glycolysis–TCA	 cycle	 bridge	 as	 well	 as	 the	
diversion	of	glucose	to	the	PPP	during	the	late	non-growth	phase	of	GS-CHO	cells	using	
13C-MFA.	 Their	 results	 are	 in	 accordance	with	 those	 reported	 here	with	 respect	 to	 a	
higher	percentage	of	pyruvate	being	 channeled	 to	AcCoA	 formation	 in	 comparison	 to	
the	 growth	 phase,	 mainly	 associated	 with	 reduced	 or	 no	 lactate	 accumulation	 in	




estimates	 using	 13C-MFA	by	Ahn	 and	Antoniewicz	 (2011,	 2013)	 in	 a	 CHO-k1	 cell	 line	




(2013)	 have	 reported	 13C-MFA	 results	 in	 a	 DHFR-deficient	 CHO	 cell	 line	 under	
industrially	 relevant	 fed-batch	 culture,	 observing	 that	 the	 proportion	 of	 PPP	 activity	
and	glycolytic	recycling,	almost	negligible	during	early	exponential	growth,	increases	to	
absorb	 all	 incoming	 glucose	 during	 late	 exponential	 and	 stationary	 growth	 phases.	
These	 studies	 also	 estimated	 significant	 anaplerotic	 fluxes	 through	 PC	 during	 the	
exponential	 phase,	 although	 generally	 limited	 to	 a	 fraction	 of	 the	 PDH	 flux,	 further	
decreasing	or	being	negligible	during	 later	phases.	The	 increase	of	PPP	activity	along	
culture	 has	 been	 suggested	 to	 counteract	 the	 excessive	 reactive	 oxygen	 species	
formation	associated	with	a	higher	oxidative	metabolism	and/or	assist	remodeling	the	
lipid	 membranes	 of	 vesicles	 for	 recombinant	 protein	 secretion,	 thus	 requiring	
production	of	a	significant	NADPH	surplus	(Ahn	and	Antoniewicz,	2012;	Sengupta	et	al.,	
2011;	Templeton	et	al.,	2013).	In	contrast,	a	lower	activity	during	earlier	growth	can	be	
in	 part	 related	 to	 a	 more	 glycolytic,	 and	 less	 oxidative,	 metabolism,	 and	 in	 part	 to	
higher	 ME	 activities	 leading	 to	 NADPH	 regeneration	 (as	 confirmed	 in	 this	 study).	
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deaminated	 to	 aspartate	 generating	 ammonia	 (Fig.	 2.6).	 In	 turn,	 around	 63%	 of	 the	
aspartate	formed	was	transaminated	to	yield	oxaloacetate	during	exponential	growth,	
decreasing	 to	 49%	 in	 the	 stationary	 phase.	 Alanine	 was	 also	 produced	 for	 nitrogen	
detoxification	during	exponential	growth,	corresponding	to	6%	of	pyruvate	usage,	but	
decreased	 to	 less	 than	 1%	 during	 the	 stationary	 phase.	 As	 mentioned	 before,	 this	
average	value	for	both	clones	 includes	a	small	production	rate	 for	the	HP	and	a	small	
consumption	 rate	 for	 the	 LP,	 which	 is,	 however,	 not	meaningful	 reflecting	 the	 slight	
delay	of	aspartate	exhaustion	in	the	HP	culture	(Fig.	2.4F).	Serine	was	the	precursor	for	
1C	 units	 metabolism,	 leading	 to	 glycine	 and	 formate	 accumulation	 (Fig.	 2.5H	 and	 I).	
Glutamine	was	not	available	in	the	culture	medium	and	was	synthesized	intracellularly	






particularly	 sustaining	 energy	 production	 throughout	 the	 culture.	 At	 the	 αKG	 node,	
most	 of	 its	 formation	 and	 consumption	 was	 due	 to	 TCA	 cycle	 activity	 via	 isocitrate	
dehydrogenase	 and	 αKG	 dehydrogenase,	 respectively	 (Fig.	 2.6).	 The	 contribution	 of	
amino	acids	metabolism	via	GLDH	and	transamination	reactions	is	collectively	limited	
to	 less	 than	 20%	 in	 either	 direction	 and	 for	 both	 exponential	 and	 stationary	 phases.	
This	is	markedly	different	from	what	is	reported	in	mammalian	cell	 lines	that	take	up	
glutamine	 from	 the	 medium	 and	 display	 high	 glutaminolysis	 rates.	 For	 instance,	
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checkpoints	 between	 clones.	 Interestingly,	 the	 contribution	 of	 ME	 activity	 was	
substantially	 higher	 in	 the	 HP,	 around	 fourfold	 and	 twofold	 for	 exponential	 and	
stationary	growth,	respectively	(for	simplicity,	these	differences	are	not	represented	in	
Fig.	 2.6).	This	 is	 in	 agreement	with	 the	 recent	 observation	 that	higher	producer	CHO	





These	 results	 show	 that	 clonal	 differences	 associated	 with	 productivity	 can	 be	 too	
subtle	 to	 investigate	by	metabolite	balancing	of	 central	metabolism	alone,	even	aided	
by	 a	 comprehensive	 exometabolome	 mapping.	 This	 is	 in	 contrast	 with	 the	 results	
obtained	 by	 Dean	 and	 Reddy	 (2013),	 which	 compared	 DHFR-CHO	 cell	 clones	 and	
concluded	 that	 the	 ability	 to	 channel	 glucose-derived	 carbon	 to	mitochondria	 fueling	
TCA	cycle	activity	was	a	distinguishing	feature	of	robust	cell	performance.	However,	an	
important	difference	to	this	work	is	that	one	of	the	clones	used	in	the	mentioned	study	
had	 markedly	 superior	 growth	 and	mAb	 accumulation	 profiles,	 as	 well	 as	 a	 distinct	
lactate	phenotype,	when	compared	to	the	other.	As	described	above,	in	the	comparison	
carried	 out	 here	 both	 clones	 were	 able	 to	 fuel	 the	 TCA	 cycle	 with	 above	 average	
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efficiencies	 even	 after	 accounting	 for	 carbon	 lost	 to	 glycerol	 production	 at	 the	DHAP	
node.	 This	 indicates	 that	 regulatory	mechanisms	 independent	 of	 central	 carbon	 flow	
influence	 recombinant	 protein	 production,	 namely	 transcriptional	 regulation	 and	 the	
cellular	redox	state,	and	that	an	in-depth	analysis	combining	multiple	levels	of	cellular	
information	 (gene	 expression,	 post-translational	 and	metabolic)	 is	 required	 to	 unveil	





represents	 the	 average	net	 flux	 in	 each	 reaction	 for	 all	 cultures	 (sets	 I,	 II,	 and	 III)	 performed	with	 both	
clones.	 For	 simplicity,	 flux	 percentages	 are	 shown	 at	 only	 some	 branch	 points.	 Metabolic	 efficiency	 is	
represented	in	pie	charts	as	the	percentage	of	carbon	flow	to	TCA	cycle	that	is	not	lost	to	glycerol	or	lactate	
formation;	carbon	diversion	to	other	metabolites	is	not	considered	for	this	calculation	(see	text).	
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including	 the	 main	 carbon	 flows	 through	 glycolysis	 and	 TCA	 cycle	 as	 well	 as	 amino	
acids	metabolism	 (Table	 2.1;	 Fig.	 2.7).	 This	 observation	 coincides	with	 the	 sustained	
IgG-specific	productivities	observed	in	the	transition	to	the	stationary	phase,	typically	
decreasing	 by	 over	 a	 third	 under	 control	 conditions	 (Fig.	 2.2C).	 These	 results	 are	 in	
accordance	 with	 a	 previous	 study	 focusing	 on	 the	 effect	 of	 butyrate	 treatment	 on	
intracellular	 nucleotide	 and	 nucleoside	 concentrations	 and	 ratios	 in	 CHO	 cells	






which	 coincided	with	 sustained	 high	 specific	 t-PA	 productivity.	 As	mentioned	 above,	
this	“delayed”	effect	on	metabolic	activity	was	evident	in	our	cultures,	since	addition	at	
24	h	had	 the	greatest	 impact	during	 stationary	phase.	 In	 terms	of	 flux	partitioning,	 a	
substantially	 lower	 contribution	 of	 lactate	 consumption	 during	 the	 stationary	 phase	
could	be	observed	at	the	pyruvate	node,	decreasing	by	nearly	half	(from	24%	to	13%)	
when	compared	to	the	average	control	(Fig.	2.7).	The	proportion	of	alanine	production	
also	significantly	 increased	on	average	 for	both	clones	due	to	aspartate	availability	 in	
all	 three	 culture	 sets,	maintaining	 levels	 comparable	 to	 exponential	 growth	 (data	not	
shown).	 Despite	 these	 alterations,	 the	 effect	 of	 butyrate	 treatment	 on	 the	 combined	
metabolic	 efficiency	 at	 the	 glycerol	 and	 lactate	 nodes	was	 small,	 increasing	 from	 the	
exponential	 phase	 to	 roughly	 100%	 during	 the	 stationary	 phase.	 Likewise,	 the	 net	
percentage	of	pyruvate	being	directed	 to	AcCoA	 formation	was	comparable	 to	 that	of	
control	 cultures,	 increasing	 from	 56%	 during	 exponential	 to	 88%	 during	 stationary	
growth	 (data	 not	 shown).	 Contextualization	 of	 these	 observations	 with	 other	 “omic”	
analyses	 in	 the	 literature	 is	 difficult	 due	 to	 lack	 of	 a	 sufficient	 coverage	 of	metabolic	
genes.	Gatti	et	al.	(2007)	were	first	to	report	a	transcriptomic	analysis	of	CHO	cultures	
as	a	response	to	butyrate	treatment,	but	the	study	coverage	was	limited	by	the	lack	of	a	
CHO	 genomic	 sequence	 and	 low	 sensitivity	 when	 performing	 cross	 species	
hybridization	 with	 hybridoma	 sequences.	 Furthermore,	 the	 authors	 compared	 cells	
before	 and	 27	 h	 after	 treatment,	 thus	 confounding	 the	 treatment	 effect	 with	 culture	
growth.	 Besides	 known	 effects	 of	 sodium	 butyrate	 pertaining	 to	 chromatin	
destabilization,	modulations	of	apoptotic	and	cell-cycle	genes,	among	others,	 the	data	
revealed	differential	expression	of	some	enzymatic	transcripts	from	glycolysis	and	lipid	
metabolism,	 in	 particular	 the	 downregulation	 of	 lactate	 dehydrogenase,	 but	 were	
insufficient	 to	 discern	 a	 consistent	 metabolic	 pattern.	 Interestingly,	 a	 general	 down-
regulation	of	the	translational	machinery	was	also	observed,	obscuring	the	reason	for	
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increased	 specific	 recombinant	 protein	 production.	 This	 phenomenon	 bears	
resemblance	 to	 that	 of	 increased	 specific	 productivity	 following	 treatment	 of	
hybridoma	 cell	 cultures	 with	 the	 mTOR	 inhibitor	 rapamycin,	 having	 been	 proposed	
that	 the	 negative	 impact	 on	 growth	 may	 free	 protein	 translation	 capacity	 to	
recombinant	 mRNAs	 or	 exert	 its	 effect	 through	 modulation	 of	 metabolic	 efficiency	
(Balcarcel	and	Stephanopoulos,	2001).	Following	on	Gatti	et	al.	(2007),	Yee	et	al.	(2008)	
compared	 CHO	 and	 hybridoma	 cell	 responses	 to	 butyrate	 treatment	 using	 species-
specific	 DNA	microarrays	with	 an	 increase	 number	 of	 probes	 and	 complemented	 by	
2D-gel	protein	electrophoresis.	They	were	able	to	shed	light	into	the	effect	on	increased	
specific	productivity,	discerning	a	consistent	trend	of	increased	protein	processing	and	
secretion	 capacity.	 This	 observation	 has	 been	 more	 recently	 corroborated	 by	
Kantardjieff	 et	 al.	 (2010),	 who	 found	 elevated	 secretory	 capacity	 under	 butyrate	
treatment	 and	 low	 temperature	 (33°C)	 conditions	 in	 a	 combined	 transcriptomic	 and	
proteomic	 study.	 Clearly,	 butyrate	 treatment	 has	 a	 generalized	 effect	 on	 cellular	




This	 work	 evaluated	 metabolic	 flux	 distributions	 of	 GS-CHO	 cell	 clones	 based	 on	
exometabolome	profiling.	Supernatant	metabolites	were	quantified	along	culture	time	
through	 1H-NMR	 under	 control	 and	 butyrate-treated	 conditions,	 allowing	 the	
identification	of	 a	 comprehensive	network	of	117	 intracellular	or	 transport	 reactions	
and	its	validation	with	experimental	data	of	24	metabolic	phases.	Estimated	fluxomes	
reveal	 higher	 metabolic	 efficiency	 than	 other	 CHO	 cell	 lines	 and	 a	 differentiated	
nitrogen	 metabolism,	 characterized	 by	 high	 asparagine	 utilization	 (instead	 of	
glutamine)	which	is	the	major	nitrogen	source	for	the	cell	and	at	the	same	time	is	used	
for	energy	generation.	Moreover,	serine	was	consumed	at	high	rates	and	fuels	1C	units	
metabolism,	 leading	 to	 glycine	 and	 formate	 accumulation.	 The	 most	 distinctive	
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observation	 in	 the	 transition	 from	 the	 exponential	 to	 the	 stationary	 phase	 was	 a	
substantial	decrease	in	metabolite	transport	rates	associated	with	a	general	depression	
in	 metabolic	 activity.	 However,	 as	 previously	 reported,	 metabolic	 efficiency	
significantly	 increases,	mainly	due	 to	 a	 shift	 from	 lactate	production	 to	 consumption.	




further	 clarify	 the	 behavior	 of	 CHO	 cells	 in	 culture	 under	 different	 growth	 and	
production	conditions.	
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Identifying	 host	 cell	 metabolic	 wphenotypes	 that	 support	 high	 recombinant	 protein	
production	is	a	major	goal	in	biotechnology.	Incubation	with	stable	13C	and	15N	isotope	
labeled	nutrients	is	a	powerful	strategy	to	map	the	flow	of	carbon	and	nitrogen	through	
intracellular	 metabolic	 pathways,	 providing	 insights	 into	 relative	 pathway	 activities	
and	nutrient	contributions.	In	this	study,	we	applied	state-of-the-art	13C	metabolomics	
based	on	GC/LC-MS	 to	analyse	 the	central	metabolism	of	GS-CHO	cells,	under	control	
and	 butyrate-treated	 conditions.	 This	 was	 achieved	 through	 short-term	 parallel	
labeling	experiments	using	[1,2-13C]glucose,	[U-13C15N]asparagine	and	[U-13C15N]serine,	
during	 the	 mid-exponential	 growth	 phase.	 Analysis	 of	 13C	 positional	 enrichment	 of	
glycolytic	 and	 pentose	 phosphate	 pathway	 (PPP)	 intermediates	 suggests	 that	 about	
30%	of	glucose	is	diverted	to	the	PPP	and	recycled	back	to	glycolysis.	Furthermore,	the	
mass	 isotopomer	 distributions	 (MID)	 of	 (G6P)	 glucose-6-phosphate	 and	 (6PG)	 6-
phosphogluconate	suggest	a	partially	cyclic	operation	of	the	PPP,	possibly	to	generate	
more	 NADPH	 for	 biosynthesis.	 Another	 important	 source	 of	 NADPH	 was	 the	 flux	
through	 the	 malic	 enzyme	 reaction,	 as	 suggested	 by	 the	 labeling	 of	 [13C]asparagine-
derived	 pyruvate.	 Noteworthy,	 asparagine	was	 essential	 for	 TCA	 cycle	 intermediates	
replenishment,	 as	 well	 as	 for	 glutamine	 synthesis	 in	 GS-CHO	 cells,	 growing	 in	 a	
glutamine-free	 culture	media.	 Asparagine	 and	 serine	were	 confirmed	 to	 be	 the	most	
important	nitrogen	sources	 in	 these	 cells,	with	 15N	 from	both	highly	present	 in	many	
non-essential	 amino	 acids.	 Finally,	 butyrate	 treatment	 increased	 significantly	 most	
measured	 intracellular	 pools.	 Furthermore,	 the	 13C	 incorporation	 data	 suggests	
butyrate	 enhances	 the	 malic	 enzyme	 activity,	 associated	 to	 increased	 NADPH	
production.	Overall,	our	results	represent	 important	 insights	 into	the	metabolism	of	a	
widely	employed	mAb-producing	CHO	cell	host.	The	identified	metabolic	traits	can	be	
explored	to	enhance	cellular	performance.	 
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of	 recombinant	 proteins	 due	 to	 their	 robust	 growth	 and	 ability	 to	 perform	 post-
translational	modifications	(Wurm	2004).	Several	culture	strategies	have	been	applied	
to	 improve	 CHO	 cells	 capabilities	 for	 protein	 production,	 such	 as	 temperature	 shift,	
media	optimization	and	chemical	approaches	(Carinhas	et	al.	2013;	Yoon	et	al.	2006;	Yu	
et	 al.	 2011).	 More	 recently,	 the	 development	 of	 systems	 biotechnology	 tools	
significantly	has	allowed	enriching	our	knowledge	about	cellular	physiology.	The	fields	
of	 genomics,	 transcriptomics	 and	 proteomics	 provide	 valuable	 information	 on	 the	
physiological	 state	 of	 a	 cell;	 whereas	 the	 metabolome	 and	 fluxome	 integrate	 the	
information	from	these	omic	layers	into	functional	phenotypic	snapshots.	In	this	sense,	
the	study	of	metabolic	phenotypes	of	CHO	cells	 in	culture	is	essential	 for	productivity	
improvement	 through	 bioprocess	 development	 and	 cell	 engineering	 (Ahn	 and	
Antoniewicz	2012).	However,	despite	the	extensive	research	on	CHO	cells,	there	is	still	
a	lack	of	comprehensive	knowledge	on	the	metabolism	of	these	cells	in	cell	culture.	
13C-based	 metabolic	 analysis	 has	 allowed	 obtaining	 the	 most	 comprehensive	
information	 to	 characterize	 cellular	 metabolic	 states,	 through	 NMR	 or	 mass	
spectrometry	(MS)	(Crown	and	Antoniewicz	2012;	Metallo	et	al.	2012;	Yang	et	al.	2006).	
The	 combination	 of	 the	 mass	 isotopomer	 analysis	 of	 metabolites	 derived	 from	 13C-
labeled	 substrates	 with	 classical	 metabolomics	 can	 have	 a	 synergistic	 effect	 on	 the	
discovery	 of	 apparently	 unrelated	 pathways	 (Yang	 et	 al.	 2006).	 So	 far,	 very	 few	 13C-
based	 metabolic	 analysis	 studies	 have	 been	 performed	 to	 study	 the	 performance	 of	
CHO	 cells	 in	 culture.	 In	 the	 last	 years,	 CHO	 cells	 behavior	 were	 studied	 elucidating	
pathways	 such	 as	 PPP	 and	 glycolysis,	 which	 could	 only	 be	 estimated	 using	 isotopic	
tracers	(Goudar	et	al.	2010;	Sengupta	et	al.	2011).	Recently,	 the	 intracellular	 fluxes	of	
CHO	 cells	 in	 batch	 culture	 were	 mapped,	 based	 on	 solely	 the	 labeling	 patterns	 of	
extracellular	metabolites	 resulting	 from	a	 [U-13C]-glucose	 feed,	highlighting	metabolic	
reversibility	 and	 compartmentation	 (Nicolae	 et	 al.	 2014).	Moreover,	 there	 have	 been	
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even	 fewer	studies	on	 the	metabolism	of	GS-CHO	cells,	a	proprietary	cell	 line	derived	
from	CHO	K1	which	uses	a	selection	system	that	couples	 the	expression	of	glutamine	
synthetase	 (GS)	 gene	with	 a	 protein	 of	 interest	 (Lonza	 Biologics,	 UK).	 This	 selection	
system	also	grants	GS-CHO	cells	the	ability	to	grow	in	a	glutamine-free	culture	medium,	
minimizing	 the	 accumulation	 of	 ammonia,	 and	making	 GS-CHO	 cells	 one	 of	 the	most	
used	industrially	(Wurm	2013).		
In	 this	work,	we	report	a	comprehensive	metabolic	 investigation	of	a	mAb-producing	
GS-CHO	 cell	 line,	 with	 and	 without	 butyrate	 treatment,	 through	 mass	 isotopomer	
distribution	 (MID)	 analysis	 of	 intracellular	 metabolites	 from	 13C-labeled	 substrates	
combined	with	exometabolome	profiling	 trough	 1H-NMR.	Three	 isotopic	 tracers	were	
used,	[1,2-13C]-glucose,	[U-13C15N]-asparagine	and	[U-13C15N]-serine,	in	order	to	explore	
the	preferred	pathways	of	each	substrate	and	evaluate	the	effect	of	butyrate	treatment	
on	 central	metabolism.	 Butyrate	 is	 a	 histone	 deacetylase	 inhibitor	with	 the	 ability	 to	
change	 chromatin	 structure,	 and	 has	 been	 empirically	 applied	 in	 the	 industry	 to	
improve	specific	productivity	of	recombinant	proteins	in	mammalian	cells	(Crowell	et	
al.	2008;	Jiang	and	Sharfstein	2008).	We	have	shown	recently	that	butyrate	treatment	
has	 a	 significant	 effect	 on	 sustaining	 the	 overall	 metabolic	 activity	 of	 GS-CHO	 cells	
(Carinhas	 et	 al.	 2013).	 Additionally,	 it	 was	 observed	 that	 most	 enzymes	 of	 central	
metabolism	are	 acetylated,	 as	 a	 result	 of	 post-translational	modifications	 (Zhao	 et	 al.	
2010),	which	are	able	to	modulate	enzyme	activity	and	increase	or	decrease	reactions	
fluxes	up	to	twofold	(Wang	et	al.	2011;	Zhao	et	al.	2010).	Further	evidence	of	butyrate’s	
effect	 on	 central	 metabolism	 is	 provided	 herein.	 The	 work	 will	 be	 presented	 in	 two	
parts:	firstly,	the	detailed	description	of	total	isotopomer	yields	and	MID	analysis	from	
parallel	labeling	experiments	under	control	conditions;	and	secondly	the	integration	of	
MID	 analysis	 of	 intracellular	 metabolites	 with	 exometabolome	 dynamics	 under	
butyrate	treatment.		
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A	 CHO	 cell	 clone	 generated	 by	 stable	 transfection	 of	 the	 CHOK1SV	 cell	 line	 with	 a	
construct	containing	GS	and	the	light	and	heavy	chains	of	an	IgG4	mAb	was	provided	by	
Lonza	Biologics.	Cells	were	maintained	in	CDCHO	chemically	defined	medium	(Cat.	No.	
10743-029,	 Gibco,	 Life	 Technologies,	 Carlsbad,	 CA)	 supplemented	 with	 25	 µM	
methionine	sulphoximine	(MSX;	Cat.	No.	M5379,	Sigma-Aldrich,	St.	Louis,	MO),	 in	125	
mL	 shake	 flasks	with	 25	mL	 culture	 volume	 and	 sub-cultured	 every	 3–4	days	with	 a	
seeding	density	of	0.4	x	106	cell/mL.	All	cultures	were	kept	 in	a	humidified	 incubator	
controlled	at	37	°C	and	7	%	CO2	with	orbital	shaking	at	130	rpm.	
In	 this	 work,	 eight	 shake	 flask	 cultures	were	 performed,	 four	with	 0.75	mM	 sodium	
butyrate	(Cat.	No.	8175000100,	Merck,	Germany)	added	24	h	after	inoculation)	and	the	





butyrate-treated	 shake	 flasks,	were	 each	 divided	 in	 four	 shake	 flasks	 –	 four	 controls	
and	 four	 butyrate-treated	 cell	 cultures.	 Addition	 of	 isotopic	 tracers	was	 done	 so	 that	
each	 pair	 of	 shake	 flasks,	 one	 control	 and	 one	 with	 butyrate,	 had	 20	 mM	 [1,2-
13C]glucose	(CIL,	MA,	USA),	two	other	had	4	mM	[U-13C/15N]asparagine	(CIL,	MA,	USA)	
and	 two	 other	 had	 4	 mM	 [U-13C/15N]serine	 (CIL,	 MA,	 USA)	 (Fig.	 3.1A).	 Remaining	
concentrations	 of	 unlabeled	 substrates	 (glucose,	 asparagine	 and	 serine)	 were	 also	
added	to	the	feed,	matching	the	concentration	of	the	labeled	substrates.	These	six	shake	
flasks	were	 used	 for	mass	 isotopologue	 distribution	 (MID)	 analysis	 throughout	 24	 h	
after	 adding	 the	 labels.	 The	 two	 remaining	 shake	 flasks	 had	 no	 [13C]	 label	 and	were	
used	 for	 1H-NMR	 analysis	 of	 the	 supernatants	 and	 quantification	 of	 intracellular	





Cell	 number	 and	 viability	were	 analyzed	 under	 a	 light	microscope	 using	 trypan	 blue	
dye	and	a	hemocytometer,	for	all	cultures.	After	counting	cells,	samples	were	clarified	
by	centrifugation	at	200	g	during	10	min	and	the	supernatant	stored	at	-20	°C	for	later	
quantification	of	 produced	 IgG4	 and	 total	 protein,	 as	well	 as	 exometabolome	analysis	
(Fig.	3.1A).	
During	 labeling	experiment,	 samples	 from	cultures	with	 [13C]	 labels	were	collected	at	




Quenching	was	 performed	 by	 rapidly	 adding	 four	 parts	 of	 ice-cold	 0.9%	 (w/v)	 NaCl	
solution	 followed	 by	 two	 cycles	 of	 1	 min	 centrifugation	 at	 1,000	 x	 g	 and	 4	 °C.	 An	
internal	 standard	 was	 added	 to	 the	 samples	 from	 the	 unlabeled	 cultures	 only,	 for	
quantification	 of	 intracellular	 metabolites,	 previous	 to	 extraction.	 Intracellular	
metabolites	 were	 then	 extracted	 in	 ice-cold	 50%	 (v/v)	 acetonitrile,	 with	 brief	
vortexing,	 incubation	 for	 10	 min	 in	 ice	 and	 snap	 freezing	 in	 liquid	 nitrogen.	 After	





Briefly,	 Nunc	Maxisorp	 96-well	 plates	 (Cat.	 No.	 437842,	 Thermo	 Scientific,	Waltham,	
MA)	 were	 coated	 with	 a	 goat	 anti-human	 IgG,	 Fcγ	 specific	 (Cat.	 No.	 109-006-098,	
Jackson	 Immunoresearch	 Labs,	 West	 Grove,	 PA)	 at	 a	 concentration	 of	 2	 µg/L	 in	
carbonate	 buffer.	 Blocking	 was	 performed	 with	 0.5%	 casein	 in	 carbonate	 buffer.	
Solutions	 with	 known	 concentrations	 of	 antibody	 were	 included	 on	 each	 plate	 for	
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with	 the	 Coomassie	 Plus	 (Bradford)	 Protein	 Assay	 reagent	 (Cat.	 No.	 23238,	 Pierce,	
Thermo	 Scientific,	 Waltham,	 MA)	 using	 Bovine	 Gamma	 Globulin	 (Cat.	 No.	 23212,	
Thermo	 Scientific)	 as	 the	 protein	 reference	 standard.	 Briefly,	 10	 µL	 of	 each	 sample	
were	mixed	in	a	microplate	with	300	µL	of	Coomassie	Plus	reagent	for	30	s.	The	plate	




500MHz	 Avance	 spectrometer	 (Bruker,	 Billerica,	 MA)	 equipped	 with	 a	 5-mm	 QXI	
inversed	 probe.	 Spectra	 were	 acquired	 using	 a	 NOESY-based	 pulse	 sequence	 with	





ratio.	Before	 spectra	acquisition,	 the	 spectrometer	was	 calibrated	by	determining	 the	
90°	 pulse	 and	 the	 water	 chemical	 shift	 centre	 of	 each	 sample.	 Each	 spectrum	 was	
phased;	baseline	corrected	and	integrated	using	the	Chenomx	NMR	Suite	7.1	(Chenomx,	
Inc.,	 Edmonton,	 Alberta,	 Canada).	 Chemical	 shifts	 of	 clusters	 used	 for	 quantification,	
correction	factors,	errors,	and	limits	are	available	in	Duarte	et	al.	(2014b).	
Ammonia	was	quantified	in	supernatant	samples	from	all	cultures	using	an	enzymatic	
kit	 (Cat.	No.	AK00091,	NZYTech,	 Lisboa,	Portugal)	 based	on	 the	measurement	 at	340	
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for	 15	 min,	 at	 room	 temperature.	 Following	 derivatization	 with	 o-phthaldialdehyde,	
samples	were	separated	on	a	Zorbax	SB-C18	(4.6	mm,	150	mm,	3.5	 lm)	column	 from	
Agilent	 using	 a	 phosphate	 buffer	 (50	 mM,	 pH	 5.9)	 and	 a	 solution	 of	 methanol	 and	
tetrahydrofurane	 (98.75%/1.25%)	 as	 eluents.	 An	 internal	 standard	 (g-aminobutyric	
acid)	 was	 added	 to	 ensure	 consistent	 measurements	 between	 runs.	 The	 separated	
amino	 acids	 were	 detected	 by	 fluorescence	 and	 quantified	 by	 comparison	 with	 a	
standard	curve	of	known	amino	acids	concentrations.		
Total	 glucose	 and	 lactate	 concentrations	 in	 the	 culture	 supernatants	 from	 the	 same	
time	 points,	 were	 also	 determined	 with	 automated	 enzymatic	 assays	 (YSI	 7100	
Multiparameter	Bioanalytical	System;	Dayton,	OH,	USA).	
3.2.8 Derivatization	of	intracellular	metabolites		
Amino	 acids,	 lactate	 and	 TCA	 cycle	 intermediates	 were	 firstly	 transformed	 to	 their	
methyloximes	 derivatives	 with	 20	 µL	 of	 O-methoxyamine	 hydrochloride	 (MOX	
solution;	Sigma	Aldrich,	DE)	in	a	pyridine	(Sigma	Aldrich,	DE)	solution	(10	mg/mL)	for	
2	h	at	40	°C.	In	a	second	step,	these	methyloximes	reacted	with	40	µL	of	MBDSTFA	at	
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the	 EI	 mode	 (70	 eV).	 The	 ionic	 source	 temperature	 was	 250	 °C,	 the	 same	 as	 the	
interface	 that	connects	 to	 the	column.	GC	was	performed	on	a	HP-5MS	column	(30	m	
length,	0.25	mm	internal	diameter,	composed	of	dimethylpolysiloxane	with	5%	phenyl	
groups,	 0.25	 µm	 film	 thickness;	 Agilent	 Technologies,	 Inc)	 in	 split	 or	 splitless	 mode	
depending	on	the	peak	intensities,	with	helium	as	carrier	gas	at	an	inlet	pressure	of	600	
kPa.	 Injections	 were	 carried	 out	 automatically	 with	 an	 AOC-5000	 Plus	 autosampler	
(Shimadzu,	 Japan)	 using	 an	 injection	 volume	 of	 1	 µL	 and	 injector	 temperature	 set	 at	
250	 °C	 (Chaves	das	Neves	 and	Vasconcelos	1987).	Mass	 spectra	were	analyzed	using	
the	 GC-MS	 Solution	 software	 version	 2.50	 SU1	 (Shimadzu,	 Japan).	 Metabolite	
identification	was	 confirmed	 by	 comparison	with	 standard	 solutions	 prepared	 in	 the	
same	 conditions	 in	 water	 and/or	 by	 spiking	 experiments	 -	 through	 the	
supplementation	 of	 the	 pure	 compounds,	 at	 different	 concentrations,	 in	 cell	 culture	






Pyr),	 and	 PPP	 intermediates	 (E4P,	 R5P,	 Ru5P,	 X5P,	 S7P)	were	 determined	 through	 a	
GC-MS-based	 analysis,	 performed	 on	 a	 GC-EI-MS	 (GC:	 7890A,	 MS:	 5975C	 Agilent	
Technologies,	Santa	Clara,	CA,	USA)	with	PTV	injection	system	(Cooled	Injection	System	
CIS4,	Gerstel	GmbH,	Mülheim	an	der	Ruhr,	Germany),	 equipped	with	a	Zebron	ZB-50	
column	 (30	 mÅ~250	 µm,	 0.25	 µm	 film	 thickness;	 Phenomenex,	 Torrance,	 CA,	 USA).	
Injection	temperature	was	set	at	300	°C	and	the	injection	volume	was	1	µl.	The	system	
was	operated	in	split-less	mode	or	in	split	mode	for	metabolites	in	high	concentration	







through	 anion	 exchange	 chromatography	 and	 electrospray	 ionization	 with	 tandem	
mass	 spectrometric	 detection	 using	 a	 HPLC	 system	 Alliance	 HT	 pump	 2795	 system	
(Waters,	USA)	combined	with	an	MS	Quattro	LC™	triple	quadrupole	(Waters,	UK).	This	















Butyrate	was	added	24	h	after	 inoculation,	when	viable	 cell	 concentration	was	1x106	
cell/ml,	 immediately	 impacting	 cell	 growth	 (Fig.	 3.1B):	 maximum	 cell	 density	 was	
limited	 to	 1.3x106	 cells/ml,	 in	 comparison	 to	 the	 3.2x106	 cells/ml	 reached	 in	 control	
conditions	after	72	h.	At	the	end	of	this	period,	similar	antibody	titres	were	reached	in	
both	 culture	 conditions	 (Fig.	 3.1C),	with	 butyrate-treated	 cultures	 showing	 a	 1.4-fold	
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increase	 in	specific	productivity	 in	comparison	 to	 the	control	 (Fig.	3.1D),	as	observed	
previously	during	the	exponential	growth	phase	(Carinhas	et	al.	2013).		
																			 	
Figure	 3.1	 (A)	 Timeline	 of	 experimental	 setup.	 Viable	 cell	 (B)	 and	 antibody	 concentration	 (IgG4)	 (C)	




cells	 in	 further	 detail,	 added	 48	 h	 after	 inoculation	 (Fig.	 3.1A).	 [1,2-13C]glucose	 was	
used	since	it	has	been	established	as	the	best	tracer	for	the	analysis	of	overall	cellular	
metabolism	 of	 mammalian	 cells	 (Antoniewicz	 et	 al.	 2007;	 Metallo	 et	 al.	 2009).	 [U-











analysed	the	distribution	of	mass	 isotopomers	 in	 intermediates	of	glycolysis,	PPP	and	
TCA	cycle,	as	well	as	 in	some	amino	acids.	Most	metabolites	did	not	reach	an	isotopic	
steady	state	24	h	after	the	isotopic	tracer	was	added	to	culture	media.	
Figure	 3.2A	 shows	 the	 MIDs	 of	 upper	 glycolysis	 and	 PPP	 throughout	 the	 labeling	
experiment.	 After	 cellular	 uptake,	 each	 molecule	 of	 glucose	 is	 phosphorylated	 to	
glucose-6-phosphate	 (G6P),	 which	 in	 turn	 can	 be	 converted	 to	 fructose-6-phosphate	
(F6P)	down	the	glycolytic	pathway,	or	used	to	generate	pentose	phosphates,	where	the	
first	 13C	 atom	 is	 lost	 as	 CO2	 (6-phosphogluconate	 dehydrogenase	 (6PGDH)	 catalysed	
reaction).	When	 the	need	 for	 reducing	power	 (NADPH)	exceeds	 the	need	 for	pentose	
precursors	 (R5P)	 for	 nucleotide	 synthesis,	 the	 PPP-derived	 F6P	 and	 G3P	 are	
transformed	 into	 pyruvate	 through	 glycolysis.	 Therefore,	 the	 ratio	 of	 M1/M2	
isotopomers	of	 glycolytic	metabolites	 (G6P,	F6P,	 FBP,	DHAP,	3PG,	PEP	and	pyruvate)	
give	an	idea	on	the	flux	partitioning	of	glucose	through	glycolysis	and	the	non-oxidative	
branch	of	PPP,	which	was	around	70	and	30	%,	respectively.	These	results	significantly	
differ	 from	 other	 studies,	 where	 non-oxidative	 PPP	 has	 been	 described	 inactive	 or	
insignificant	 during	 early	 exponential	 phase	 of	 both	 non-producing	 (Ahn	 and	
Antoniewicz	2011)	and	producing	CHO	cell	lines	(Templeton	et	al.	2013).		
Interestingly,	the	high	abundance	of	M1	G6P	(14%)	and	M1	6PG	(20%),	24	h	after	label	
was	 added,	 which	 are	metabolites	 upstream	 to	 the	 reaction	 where	 the	 loss	 of	 13CO2	
occurs	(6PGDH	enzyme),	suggests	that	oxidative	PPP	is	operating	in	cyclic	mode,	with	
considerable	conversion	of	F6P	 into	G6P.	This	 feature	has	been	described	 for	 the	 late	
exponential	phase	of	CHO	cell	cultures,	when	the	glucose-6-phosphate	dehydrogenase	
(G6PDH)	flux	was	determined	to	be	greater	than	the	hexokinase	(HK)	flux	(Templeton	
et	 al.	 2013).	 The	 recycling	 of	 G6P	 from	PPP-derived	 F6P	may	 represent	 an	 energetic	
advantage,	 since	 the	 redox	 energy	 of	 glucose	 can	 be	 conserved	 as	 NADPH	 at	 the	
expense	of	only	one	carbon	per	G6P	(Bouzier-Sore	and	Bolanos	2015).	As	S7P	results	
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of	 the	glucose	 consumed	was	 secreted	as	 lactate.	The	 remaining	glucose	entering	 the	
cells	 can	 be	 either	 channelled	 to	 the	 TCA	 cycle	 or	 diverted	 to	 biosynthesis.	 Fig.	 3.2C	
shows	 the	 MIDs	 of	 TCA	 cycle	 metabolites	 citrate,	 αKG	 and	 malate,	 which	 were	
essentially	 also	 M1	 and	 M2	 isotopomers.	 At	 24	 h	 post-label	 addition	 approximately	
85%	of	 citrate	had	 glucose-derived	 carbon,	 but	 only	73%	of	 αKG	and	43%	of	malate	






(about	 1.3%	 each	 at	 24	 h),	 only	M1	 glycine	 (0.9%)	was	 observed	 due	 to	 loss	 of	 one	
labeled	 carbon	 during	 conversion	 of	 serine	 to	 glycine.	 Finally,	 we	 could	 not	 detect	
measurable	 label	 incorporation	 into	 asparagine	 from	 the	 glucose	 tracer	 (data	 not	
shown),	which	suggests	inactivity	of	asparagine	synthetase.		
	




Figure	 3.2	 -	 Mass	 isotopomer	 distribution	 profiles	 for	 [1,2-13C]-glucose	 experiment,	 during	 24	 h	 after	
isotopic	tracer	feed.	(A)	Upper	glycolysis	and	PPP	(B)	Lower	glycolysis	and	pyruvate	branch	(C)	TCA	cycle	
intermediates	and	related	amino	acids.	Initial	labeled-glucose	in	cell	culture	was	58%.	
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among	 other	measured	 amino	 acids,	 namely	 glutamate	 (27%),	 glutamine	 (31%)	 and	
alanine	(19%),	which	suggests	that	it	corresponds	to	the	amine	group.			
																					 	
Figure	 3.3	 Simplified	 model	 for	 GS-CHO	 cell	 metabolism	 in	 cultures	 with	 fully	 labeled	 [U-13C/15N]-
asparagine,	 in	 control	 condition.	 Representation	 of	 the	 two	 most	 prevalent	 mass	 isotopomers,	 in	
intracellular	metabolites,	detected	24	h	after	isotopic	tracer	feed.	Circles	and	squares	represent	carbon	and	
nitrogen	atoms,	respectively;	in	full,	if	labeled;	or	empty,	without	label.		
These	 results	 are	 in	 agreement	 with	 Huang	 and	 colleagues’	 work,	 who	 studied	 the	
nitrogen	metabolism	of	asparagine	and	glutamate,	as	glutamine	replacers,	in	Vero	cells	




nitrogen	 of	 asparagine	was	 essentially	metabolized	 to	 the	 amine	 group	 of	 aspartate,	
glutamate	 and	 glutamine;	 while	 the	 amide	 group	 of	 asparagine	 would	 be	 used	 as	
ammonia	 source	 for	 glutamine	 synthesis,	 where	 it	 would	 appear	 also	 in	 the	 amide	






asparagine	 as	 nitrogen	 source	 to	 fuel	 alanine	 production	 (Dean	 and	 Reddy	 2013;	
Duarte	et	al.	2014a).		
Noteworthy,	pyruvate	mass	isotopomers	M3	(11%)	and	M1	(3%)	were	observed	(Fig.	
3.4B).	 One	 possible	 explanation	 for	 the	 isotopomer	 distribution	 of	 pyruvate	 is	 the	
oxidative	 decarboxylation	 of	 malate	 into	 pyruvate	 through	 the	 activity	 of	 malic	
enzymes	(ME)	(Wahrheit	et	al.	2014).	The	[13C]	label	on	pyruvate	could	have	not	come	
from	any	other	 source,	 considering	PEP	and	other	glycolytic	 intermediates	presented	
no	 [13C]	 enrichment	 (data	 not	 shown).	 Malic	 enzymes	 are	 required	 for	 maintaining	
NADPH	cellular	levels	as	well	as	having	a	regulatory	role	in	TCA	flux	matching	cellular	
demand	 for	 energy	 and	 biosynthetic	 precursors	 (Jiang	 et	 al.	 2013).	 Therefore,	 these	
results	could	also	confirm	that	a	cycle	involving	malic	enzymes	and	PC	may	take	a	key	
role	during	exponential	growth	phase	in	replenishing	NADPH	(Dean	and	Reddy	2013;	
Templeton	 et	 al.	 2013).	 The	 MID	 profiles	 of	 glycolytic	 intermediates	 did	 not	 show	
significant	 labeling	 from	 [U-13C]asparagine,	 even	 after	 24	 h,	 suggesting	 that	 the	
gluconeogenesis	pathway	was	negligible	in	these	cells.	
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The	 total	 asparagine-derived	carbon	at	24	h	post-label	 addition	 in	 the	TCA	cycle	was	
50%	 for	 citrate,	 and	 53%	 for	 fumarate	 and	 malate.	 The	 utilization	 of	 asparagine	 to	
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replenish	TCA	cycle	 intermediates	has	been	shown	 important,	particularly	during	 the	
exponential	 phase	 (Dean	and	Reddy	2013).	 Interestingly,	 the	11%	M4	approximately	













Figure	 3.5	 Mass	 isotopomer	 distribution	 profiles	 for	 [U-13C/15N]serine	 experiment,	 during	 24h	 after	
isotopic	tracer	feed.		




post-label	 addition.	 Interestingly,	 intracellular	 alanine	 M1	 was	 8%	 24	 h	 post-label	
addition.	As	the	carbon	backbone	of	alanine	derives	from	pyruvate,	which	is	very	little	
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labeled,	 the	 M1	 of	 alanine	 should	 correspond	 to	 15N	 enrichment,	 as	 previously	
discussed	 for	 the	 asparagine-derived	 alanine.	 Furthermore,	 the	 M1	 isotopomer	 of	
glutamate	 (3%),	 glutamine	 (3%)	 and	 aspartate	 (4%)	 suggests	 serine	 is	 also	 an	
important	nitrogen	donor	 in	GS-CHO	cells,	although	contributing	much	 less	to	the	15N	
enrichment	 than	 asparagine.	 Low	 label	 values	 on	 most	 glycolytic	 and	 TCA	 cycle	
metabolites	suggest	the	low	utilization	of	serine	as	catabolic	substrate.		
3.3.3 Impact	of	butyrate	on	metabolome	and	13C	label	distribution		
Sodium	 butyrate	 is	 a	 histone	 deacetylase	 inhibitor	 that	 has	 been	 widely	 adopted	 in	
industry	to	improve	the	production	of	recombinant	proteins	(McMurray-Beaulieu	et	al.	
2009).	Although	its	effect	on	metabolism	is	poorly	known,	it	was	demonstrated	to	have	
a	 significant	 impact	 on	 sustaining	 high	 nutrient	 consumption	 along	 culture	 time,	
especially	during	stationary	phase,	when	IgG	formation	is	more	pronounced	(Carinhas	
et	 al.	 2013).	 In	 this	 study,	 our	 aim	 was	 to	 investigate	 in	 more	 detail	 CHO	 cell	
metabolism	in	the	presence	of	sodium	butyrate,	recurring	to	the	use	of	labeled	isotopic	
tracers.	Our	hypothesis	 is	 that	while	butyrate	 causes	 cell	 growth	arrest	 (Fig.	3.1B),	 it	




to	 control	 cultures,	 suggesting	 a	 higher	 metabolic	 efficiency	 (Carinhas	 et	 al.	 2013;	
McMurray-Beaulieu	 et	 al.	 2009).	 Glutamine,	 alanine,	 glycine	 and	 ammonia	 were	
secreted	to	the	media	at	rates	over	2-fold	higher	under	butyrate-treated	condition.	By	
turn,	glycerol	secretion	was	reduced	to	half	in	butyrate	treated	cultures.		
Interestingly,	 the	 intracellular	 concentration	 pools	 of	 most	 metabolites	 measured	 in	
butyrate-treated	cultures	were	2.5-fold	higher	(in	average)	when	compared	to	control	
cultures	 (Fig.	 3.6).	 These	 results	 correlate	 with	 the	 observed	 increase	 in	 cell	 size	
(Carinhas	et	al.	2013).	Noteworthy,	glutamine	intracellular	pool	was	approximately	4-
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fold	 higher	 in	 cells	 under	 butyrate	 treatment.	 This	 may	 be	 due	 to	 higher	 glutamine	
synthetase	abundance,	which	is	being	expressed	from	the	same	locus	of	the	IgG4	heavy	
and	 light	 chains,	 correlating	 with	 an	 increased	 specific	 protein	 production	 rate.	 It	 is	
known	 that	 the	 human	 cytomegalovirus	 promoter	 (PCMV)	 driving	 expression	 of	 the	
genes	 of	 interest	 has	 high	 susceptibility	 to	 methylation	 (Kim	 et	 al.	 2011),	 and	 its	
epigenetic	 silencing	 has	 recently	 been	 shown	 to	 occur	 also	 via	 histone	 methylation	
(Meilinger	et	al.	2009).	Therefore,	butyrate	seems	to	prevent	methylation,	at	the	same	
time	that	it	sustains	acetylation,	keeping	this	region	of	the	chromatin	in	an	open	state.	
These	 two	 epigenetic	 mechanisms,	 demethylation	 and	 histone	 (or	 non-histone	
proteins)	acetylation,	have	been	associated	to	gene	expression	up-regulation	in	several	
mammalian	 cell	 lines	 (Camolotto	 et	 al.	 2013;	 Gu	 et	 al.	 2013;	 Ma	 and	 Schultz	 2008;	
Paredes	et	al.	2013).		
	
Figure	 3.6	 Total	 intracellular	 metabolite	 pools	 ratio	 butyrate/control	 for	 amino	 acids,	 TCA	 cycle	 and	
glycolytic	intermediates.		
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The	 two	 glycolytic	 intermediates	 2PG	 and	 3PG	 have	 pools	 3-fold	 higher	 in	 butyrate-
treated	 cultures.	 Citrate	 is	 another	 metabolite	 which	 has	 its	 abundance	 significantly	




Overall,	 the	 labeling	 dynamics	 from	 control	 and	 butyrate-treated	 cell	 cultures	 were	
similar	 (Fig.	 3.7),	 indicating	 that	 essentially	 the	 same	metabolic	 routes	 are	 operating	
after	butyrate	addition,	 although	quantitative	 flux	differences	 should	exist	because	of	
the	differences	observed	in	the	uptake/secretion	rates.		
The	mass	 isotopomer	enrichment	values	 collected	after	24	h	of	 incubation	with	 [1,2-
13C]glucose	for	control	and	butyrate-treated	conditions	are	compiled	on	Fig.	3.7A.	PEP	
M1	 (8%)	 was	 50%	 higher	 in	 the	 butyrate-treated	 condition	 when	 compared	 to	 the	
control,	 while	 for	 pyruvate	 (6%)	 and	 F6P	 (20%)	 the	 [M1]	 increased	 42%	 and	 10%,	
respectively.	However,	the	[M1]/[M2]	ratios	of	these	metabolites	were	not	significantly	
different	 between	 conditions,	 and	 therefore	 indicative	 of	 a	 similar	 relation	 between	
glycolysis	and	PPP.		
Some	 differences	 are	 also	 observed	 in	 asparagine	 labeled	 cultures	 (Fig.	 3.7B).	 For	
instance,	butyrate	 treatment	 led	 to	 increases	on	pyruvate	M3	by	40%	which	suggests	
that	 butyrate	 may	 induce	 an	 increase	 of	 the	 malate-pyruvate	 cycle	 activity	 with	
concomitant	increase	of	PC	activity,	as	mentioned	previously	for	the	control	condition.	
Malic	 enzymes,	 which	 catalyze	 the	 oxidative	 decarboxylation	 of	 malate	 to	 generate	
pyruvate	 and	 NADPH,	 would	 this	 way	 supply	 mitochondrial	 pyruvate	 pool,	
compensating	any	insufficient	pyruvate	transport	capacity	from	the	cytosol	(Wahrheit	
et	 al.	 2014).	 An	 increase	 in	 NADPH	 production	 could	 act	 as	 a	 counter	 measure	 to	
excessive	 reactive	 oxygen	 species,	 or	 as	 cofactor	 in	 lipid	 and	 nucleic	 acid	 synthesis,	
being	 the	main	 reductive	 power	 source	 (Ahn	 and	 Antoniewicz	 2012;	 Sengupta	 et	 al.	
2011;	Templeton	et	al.	2013).	Additionally,	a	surplus	of	NADPH	could	fuel	folate	cycle	
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and	 the	 regeneration	 of	 glutathione,	 important	 for	 the	 maintenance	 of	 the	 ratio	
between	 NADPH	 and	 NADP+,	 through	 its	 ability	 to	 reduce	 reactive	 oxygen	 species	
(Locasale	2013;	Sengupta	et	al.	2011).	Butyrate	had	no	significant	impact	on	the	[13C]-
label	 enrichment	 of	 metabolites	 derived	 from	 [U-13C/15N]-serine	 (data	 not	 shown).	





Figure	 3.7	(A)	MID	of	 intracellular	metabolites	 derived	 from	 [1,2-13C]glucose,	 under	 control	 (black)	 and	
butyrate-treated	 (red)	 conditions,	 after	 24	 h.	 (B)	 MID	 of	 intracellular	 metabolites	 derived	 from	 [U-
13C/15N]asparagine,	 under	 control	 (black)	 and	 butyrate-treated	 (red)	 conditions,	 after	 24	 h.	 Butyrate-
treated	results	were	normalized	for	comparison	with	control	condition.	
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Over	 the	 recent	 past,	 increased	 efforts	 on	 analytical	 and	 computational	 fronts	 have	
allowed	 more	 comprehensive	 and	 detailed	 analysis	 of	 flux	 distributions	 in	 cultured	
cells	 that	 can	 guide	 the	design	of	 cell	 and	process	 engineering	 strategies	 to	meet	 the	
requirements	 of	 improved	 production	 titers.	 Recent	 publications	 have	 addressed	 the	
metabolism	 of	 producer	 and	 non-producer	 CHO	 cell	 lines	 using	 different	 labeled	
substrates.	In	this	work,	we	used	a	range	of	methods	to	characterize	the	metabolism	of	
GS-CHO	 cells	 during	 exponential	 growth	 and	 butyrate	 treatment.	 The	 CHO	 cell	 clone	
used	 in	 this	 study	 produces	 a	 recombinant	 mAb	 at	 relatively	 high	 rates	 during	 the	
exponential	phase	 (30	pg/cell/day),	while	butyrate	enhanced	specific	productivity	by	
1.4-fold	 (approx.	 45	 pg/cell/day).	 One	 of	 the	 most	 distinct	 features	 of	 this	 high	




malic	enzyme	 in	control	conditions,	and	 importantly,	 it	seems	to	be	enhanced	 in	cells	
under	butyrate	treatment.	Therefore,	a	high	flux	through	pathways	in	which	NADPH	is	
generated	 seems	 to	 be	 necessary	 to	 support	 mAb	 synthesis.	 Asparagine	 and	 serine	
were	 highlighted	 as	 important	 nitrogen	 sources,	 namely	 for	 glutamine	 and	 alanine	
synthesis.		
Aside	 from	 a	 general	 upregulation	 of	 cellular	 carbon	 metabolism	 upon	 butyrate	
addition,	we	have	identified	specific	altered	metabolite	pools	which	could	be	explored	
as	 targets	 in	 future	 optimization	 of	 production	 processes	 of	 recombinant	 proteins	 in	
these	cells.	
Overall,	 this	 work	 contributes	 to	 unfold	 important	 insights	 into	 GS-CHO	 cells	
metabolism.	 Ongoing	 is	 the contextualization of the data from the parallel labeling 
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cultures into a metabolic network model for	detailed	mapping	of	cellular	fluxomes	in	
each	scenario.	13C	stable	isotope	labeling,	when	combined	with	metabolic	flux	analysis	
(MFA),	 allows	 the	 greatest	 quantitative	 interrogation	 of	 cellular	 metabolic	 activity	
(Wiechert	 2001).	Although	being	 considerably	more	demanding,	 both	 experimentally	
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Abstract 
Chinese	 hamster	 ovary	 (CHO)	 cells	 are	 the	 predominant	 host	 for	 production	 of	





energy	 generation	 are	 poorly	 understood.	 In	 this	work,	 a	 comprehensive	 profiling	 of	
extracellular	metabolites	 coupled	with	 an	 analysis	 of	 intracellular	 label	 distributions	
after	1-13C-pyruvate	supplementation	were	used	to	trace	metabolic	rearrangements	in	
different	scenarios	of	asparagine	and	serine	availability.	The	absence	of	asparagine	 in	
the	 medium	 caused	 growth	 arrest,	 and	 was	 associated	 with	 a	 dramatic	 increase	 in	
pyruvate	uptake,	 a	higher	 ratio	of	pyruvate	carboxylation	 to	dehydrogenation	and	an	
inability	 for	 de	 novo	 asparagine	 synthesis.	 The	 release	 of	 ammonia	 and	 amino	 acids	
such	 as	 aspartate,	 glutamate	 and	 alanine	 were	 deeply	 impacted.	 This	 confirms	




and	 formate	 secretion	 congruent	 with	 its	 role	 as	 a	 precursor	 in	 the	 metabolism	 of	































Chinese	 hamster	 ovary	 (CHO)	 cells	 are	 preferred	 mammalian	 hosts	 for	 industrial	
production	of	therapeutic	glycoproteins	such	as	monoclonal	antibodies	(mAbs)	used	to	
treat	 cancer	 and	 immunological	 disorders	 (Walsh,	 2010).	 Earlier	 rational	 efforts	
towards	 bioprocess	 optimization	 allowed	 the	 identification	 of	 conditions	 supporting	
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better	 cell	 growth	 and	 recombinant	 protein	 production	 (Butler,	 2005;	Wurm,	 2004).	
However,	fundamental	knowledge	on	the	metabolic	behavior	of	cells	in	culture	and	its	
impact	 on	 product	 yield	 and	 critical	 quality	 attributes	 (folding,	 glycosylation,	
aggregation)	have	not	been	yet	systematized	(Carinhas	et	al.,	2012).		
Like	 other	 mammalian	 cell	 lines,	 CHO	 cells	 fuel	 carbon	 and	 nitrogen	metabolism	 by	
taking	up	high	quantities	of	glucose	and	glutamine	 from	 the	medium,	while	 releasing	
lactate	and	ammonia	as	by-products	 (Neermann	and	Wagner,	1996).	Glutamine	plays	
an	 important	role	not	only	as	a	nitrogen	source	but	also	as	an	anaplerotic	metabolite	
fueling	 biosynthesis	 and	 energy	 generation	 (Csibi	 et	 al.,	 2013).	 The	 dependency	 of	
mammalian	 cell	 lines	 on	 exogenous	 glutamine	 has	 been	 explored	 as	 a	 means	 to	
generate	 the	 glutamine	 synthetase	 (GS)	 expression	 system	 for	 recombinant	 protein	
production.	This	system	is	based	on	transfecting	cells	with	a	plasmid	expressing	both	
GS	 and	 the	 protein-of-interest	 to	 enable	 selection	 of	 cells	 in	 glutamine-free	 media	
(Bebbington	 et	 al.,	 1990;	 Cockett	 et	 al.,	 1990).	 CHO	 cell	 lines,	 in	 particular,	 express	
sufficient	 endogenous	 GS	 to	 survive	 without	 external	 glutamine;	 in	 this	 case,	 the	
specific	 GS	 inhibitor	methionine	 sulfoximine	 (MSX)	 is	 used	 to	 inhibit	 endogenous	 GS	
activity	such	that	only	transfectants	with	additional	recombinant	GS	activity,	and	hence	
recombinant	protein	expression,	can	survive	(Birch	and	Racher,	2006).	This	system	has	
enjoyed	 popularity	 in	 large-scale	 monoclonal	 antibody	 production,	 offering	 a	 fast	
technology	to	establish	stable,	high-producing	cells	with	 the	added	bonus	of	reducing	
ammonia	 accumulation	 and	 avoiding	 its	 deleterious	 effects	 on	 culture	 performance	
(Yang	and	Butler,	2000;	Cruz	et	al.,	2000).		
In	 comparison	 to	 cells	 with	 a	 highly	 active	 glutaminolysis	 pathway,	 amino	 acids	
metabolism	 in	 GS-CHO	 cells	 is	 poorly	 known.	 GS-catalyzed	 formation	 of	 glutamine	
occurs	 with	 glutamate	 being	 phosphorylated	 before	 reacting	 with	 ammonia	 to	 form	
glutamine.	GS-CHO	cells	survive	without	exogenous	glutamine	in	the	medium	by	using	
glutamate	 and	 other	 amino	 acids	 such	 as	 asparagine	 (Zhang	 et	 al.,	 2006).	 From	
previous	 work	with	 GS-CHO	 cell	 clones,	 we	 have	 observed	 that	 serine	 is	 the	 second	
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most	 consumed	 amino	 acid	 next	 to	 asparagine	 (Carinhas	 et	 al.,	 2013).	 Besides	 being	
used	 in	 proliferating	 cells	 for	 the	 synthesis	 of	 proteins,	 glycine,	 cysteine,	 nucleotides	
and	lipids,	serine	is	the	major	source	of	one-carbon	units	for	methylation	reactions	(Ye	
et	al.,	2012).	Importantly,	the	formation	of	serine-derived	formate	has	been	observed	in	





culturing	 cells	 in	 the	 absence	 of	 each	 amino	 acid,	 and	 ii)	 by	 culturing	 cells	 in	 the	
presence	 of	 a	 low	 concentration	 of	 either	 amino	 acid.	 The	 consumption	 of	metabolic	
substrates,	 secretion	 of	 by-products	 and	 culture	 performance	 indicators	 (cell	 density	
and	 monoclonal	 antibody	 titer)	 were	 followed	 in	 the	 different	 scenarios.	 1H-NMR	
spectroscopy	 was	 used	 to	 simultaneously	 quantify	 a	 large	 number	 of	 metabolites	 in	
culture	 supernatant	 (Duarte	 et	 al.,	 2014).	 Furthermore,	we	 exploited	 carbon-labeling	







(Cat.	 No.	 10743-029,	 Gibco,	 Life	 Technologies,	 USA),	 customized	without	 asparagine,	
serine	 and	 glucose,	 was	 supplemented	 with	 5	mM	 asparagine,	 5	 mM	 serine,	 50	mM	
glucose	 and	25	µM	MSX.	Cells	were	maintained	 in	125	ml	 shake	 flasks	with	25	ml	of	
culture	 volume	 and	 sub-cultured	 every	 3–4	 days	with	 a	 seeding	 density	 of	 0.45×106	
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serine)	 and	daily	 feeding	of	 1	mM	asparagine,	 or	 ii)	 1	mM	serine	 (5	mM	asparagine)	
followed	by	daily	feeding	of	0.5	mM	serine,	or	iii)	without	asparagine	(5	mM	serine),	or	
iv)	without	 serine	 (5	mM	asparagine).	 Samples	were	 collected	at	 intervals	of	8–14	h.	
Cell	density	and	viability	were	determined	by	the	trypan	blue	dye	exclusion	assay.	After	
cell	counting,	samples	were	clarified	by	centrifugation	at	200	x	g	during	10	min	and	the	
supernatant	 stored	 at	 −20°C	 for	 later	 quantification	 of	 produced	 IgG4	 and	
exometabolome	analysis.		
4.2.3 Cultures	with	1-13C-pyruvate	supplementation		
1-13C-labeled	 pyruvate	 (CLM-1082-0.25,	 Cambridge	 Isotope	 Laboratories,	 UK)	 was	
added	 in	 cultures	 without	 asparagine	 or	 without	 serine;	 duplicate	 cultures	 were	
performed	for	each	scenario,	paralleled	by	two	independent	sets	of	duplicate	controls	





1H-NMR	 spectra	 acquisition	 of	 culture	 supernatants	 was	 performed	 in	 a	 500	 MHz	
Avance	spectrometer	(Bruker,	USA)	equipped	with	a	5	mm	QXI	inversed	probe.	Spectra	
were	 acquired	 using	 a	 NOESY-based	 pulse	 sequence	 with	 water	 presaturation,	
performing	256	scans	with	4	s	acquisition	time,	1	s	relaxation	delay	and	100	ms	mixing	
time	 at	 25	 °C.	 Deuterated	 3-(trimethylsilyl)-1-propanesulfonic	 acid	 sodium	 salt,	 2,2-
Dimethyl-2-silapentane-5-sulfonate-d6	 sodium	 salt	 (DSS-d6)	 was	 used	 as	 internal	
standard	 for	metabolite	quantification	 in	all	 samples.	 In	order	 to	maintain	a	 constant	
pH	 between	 samples,	 these	were	mixed	with	 phosphate	 buffer	 (pH	 7.4)	 prepared	 in	
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D2O	at	a	2:1	ratio.	The	spectrometer	was	firstly	calibrated	by	determining	the	90°	pulse	
and	 the	 water	 chemical	 shift	 centre	 of	 each	 sample.	 Each	 spectrum	 was	 phased,	
baseline	 corrected	 and	 integrated	 using	 the	 Chenomx	 NMR	 Suite	 7.1	 (Chenomx	 Inc.,	
Canada).	The	 assignment	of	metabolites	was	made	by	 comparison	with	 software	 and	
public	databases	or	spiking	experiments	with	pure	compounds.	Details	on	peak	cluster	
integration	 and	 chemical	 shifts	 used	 for	 quantification	 can	 be	 found	 in	 Duarte	 et	 al.	
(2014).		
Ammonia	was	quantified	using	an	enzymatic	kit	(Cat.	No.	AK00091,	NZYTech,	Portugal)	





coated	 with	 a	 goat	 anti-human	 IgG,	 Fcγ-specific	 (Cat.	 No.	 109-006-098,	 Jackson	
Immunoresearch	Labs,	USA)	at	a	concentration	of	2	µg/L	in	carbonate	buffer.	Blocking	
was	 performed	with	 0.5	%	 casein	 in	 carbonate	 buffer.	 Bound	 antibody	was	 detected	
with	 goat	 anti-human	 IgG	 (Fab-specific)-peroxidase	 antibody	 (Cat.	 No.	 A0293,	
Sigma-Aldrich,	 USA)	 and	 TMB	 substrate	 (Cat.	 No.	 00-2023,	 Invitrogen,	 Life	
Technologies,	 USA).	 2.5	 M	 sulphuric	 acid	 was	 used	 as	 stop	 solution	 and	 color	
development	was	measured	at	450	nm.		
4.2.6 Sampling	and	extraction	of	intracellular	metabolites	





vortexing	 and	 snap	 freezing	 in	 liquid	 nitrogen.	 After	 thawing	 on	 ice,	 samples	 were	
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centrifuged	 for	 10	min	 at	 15	000	 x	 g	 and	4	°C.	 The	 supernatants	 (cell	 extracts)	were	
dried	by	vacuum	centrifugation	overnight	and	stored	at	4	°C	until	derivatization.	
4.2.7 Derivatization	of	intracellular	metabolites	
Two	 derivatization	 methods	 were	 adopted	 for	 two	 sets	 of	 metabolites	 (Hofmann	 et	
al.2008).	 Briefly,	 amino	 acids	 and	 lactate	 were	 derivatized	 to	 their	 tert-
butyldimethylsilyl	 derivatives	 with	 10	 µL	 of	 N-tert-butyldimethylsilyl-N-
methyltrifluoroacetamide	 (MBDSTFA;	 Aldrich,	 DE)	 and	 30	 µL	 of	 dimethylformamide	
(DMF;	 Sigma	 Aldrich,	 DE)	 at	 75	 °C	 for	 30	 min.	 Tricarboxylic	 acids	 were	 firstly	
derivatized	to	their	methyloximes	with	20	µL	of	O-methylhydroxylamine	hydrochloride	
(Sigma	Aldrich,	DE)	 in	a	pyridine	(Sigma	Aldrich,	DE)	solution	(10	mg/mL)	 for	2	h	at	
40	 °C.	 In	a	second	step,	 these	methyloximes	were	reacted	with	40	µL	of	MBDSTFA	at	




the	 EI	 mode	 (70	 eV).	 The	 ionic	 source	 temperature	 was	 250	 °C,	 the	 same	 as	 the	
interface	 that	connects	 to	 the	column.	GC	was	performed	on	a	HP-5MS	column	(30	m	
length,	0.25	mm	internal	diameter,	composed	of	dimethylpolysiloxane	with	5	%	phenyl	
groups,	 0.25	 µm	 film	 thickness;	 Agilent	 Technologies,	 Inc)	 in	 1:10	 split	 mode,	 with	






in	 water	 and/or	 by	 spiking	 experiments	 -	 through	 the	 supplementation	 of	 the	 pure	
compounds,	 at	 different	 concentrations,	 in	 cell	 culture	 medium.	 Mass	 isotopomer	
distributions	 were	 obtained	 by	 integration	 of	 ion	 chromatograms	 and	 corrected	 for	






The	main	metabolic	 rearrangements	 undertaken	 by	 two	mAb-producing	 GS-CHO	 cell	








Residual	asparagine	 from	the	cell	 inoculum	(0.1	mM)	 lasted	 less	 than	48	h	 in	culture,	
allowing	cells	 to	grow	 to	around	1×106	 cells/mL	and	remaining	at	approximately	 the	
same	 concentration	 during	 144	 h	 of	 culture	 (Fig.	 4.1).	 Comparing	 to	 the	 exponential	
phase	of	the	control,	asparagine	uptake	was	expectedly	decreased	while	ammonia	and	
alanine	were	not	produced,	both	displaying	negligible	consumption	rates	(Figs.	4.2	and	
4.3).	 Interestingly,	 serine	 and	 aspartate	 consumption	 rates	 more	 than	 doubled	 to	
compensate	 decreased	 asparagine	 uptake,	 with	 concomitant	 increased	 production	 of	
formate	 and	 glycine	 (Figs.	 4.2	 and	 4.3).	 Although	 glucose	 consumption	 rate	 was	 not	
substantially	affected,	an	increase	of	around	2-fold	in	lactate	production	was	observed.	




Of	more	relevance,	a	 large	 increment	 in	pyruvate	uptake	 (over	10-fold)	 in	 relation	 to	
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the	control	took	place,	leaving	the	compound	practically	exhausted	after	the	initial	48	h	
of	culture	(Figs.	4.2	and	4.3).	This	likely	indicates	an	anaplerotic	role	of	this	metabolite	









control	 culture	 (Fig.	 4.2).	 Linked	 to	 the	 consumption	 of	 these	 amino	 acids	 was	 the	
production	of	both	ammonia	and	alanine,	contrasting	with	a	net	ammonia	consumption	
and	 also	 a	minor	 alanine	 production	 rate	 during	 the	 stationary	 phase	 of	 the	 control	
(Figs.	4.2	and	4.3).	While	serine	consumption	drastically	decreased	in	the	transition	to	
the	stationary	phase	of	the	control,	it	only	modestly	decreased	after	growth	halt	in	the	
culture	with	 residual	 initial	 asparagine;	 consistently,	higher	 secretion	 rates	of	glycine	
and	 formate	 were	 observed	 in	 the	 later	 scenario.	 Interestingly,	 glucose	 and	 choline	
consumption	were	over	3	and	5-fold	higher	 than	 in	 the	control	during	 the	 respective	
non-growth	 phases	 (Table	 SI).	 Related	 with	 higher	 choline	 uptake,	 its	 by-products	
phosphocholine	and	glycerol-3-phosphocholine	were	accumulated	at	higher	rates.		
	 	









The	TCA	cycle	 intermediates	 fumarate	and	malate,	which	 typically	start	accumulating	
in	the	supernatant	at	the	end	of	the	exponential	phase,	 failed	to	do	so	throughout	the	
entire	 duration	 of	 the	 culture	 without	 asparagine	 (Figs.	 4.2	 and	 4.3,	 Table	 SI).	 This	
indicates	 the	cataplerotic	assimilation	of	asparagine	 is	 related	 to	 the	buildup	of	 these	
carboxylates,	 however	 likely	 not	 as	 their	 direct	 carbon	 source	 since	 asparagine	 is	
depleted	during	the	stationary	phase	of	the	control	culture	when	most	of	the	fumarate	
and	malate	 secretion	 occurs.	 This	 is	markedly	 different	 from	 the	 cases	 of	 citrate	 and	
succinate	 (Fig.	 4.2	 and	 Table	 SI),	 which	 start	 accumulating	 at	 the	 culture	 onset,	
displaying	 similar	 or	 slightly	 higher	 rates	 when	 compared	 to	 the	 control	 during	 the	
respective	growth	phases.	
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asparagine	 concentrations,	 including	 growth,	 productivity	 (data	 not	 shown)	 and	
metabolic	 behavior.	 However,	 the	 stationary	 phase	 of	 the	 culture	maintained	 at	 low	
asparagine	 concentration	 is	 characterized	 by	 the	 availability	 of	 this	 amino	 acid	 (Fig.	
4.1),	which	 is	 taken	up	at	 approximately	 the	 same	rate	as	during	exponential	 growth	
(Fig.	 4.3),	 whereas	 in	 the	 control	 the	 onset	 of	 the	 stationary	 phase	 coincides	 with	
asparagine	depletion.	As	the	growth	profiles	of	both	cultures	practically	match,	we	can	




Correlated	 with	 asparagine	 availability	 throughout	 culture	 time	 was	 an	 interesting	
modulation	 in	 nitrogen	 metabolism:	 not	 only	 alanine	 and	 ammonia	 continued	 to	 be	
secreted;	 there	 was	 also	 a	 shift	 from	 aspartate	 and	 glutamate	 consumption	 to	
production,	while	glutamine	secretion	also	 increased	significantly	 (see	profiles	 in	Fig.	
4.2).	Furthermore,	reinforcing	the	mentioned	relationship	between	asparagine,	malate	
and	 fumarate,	 both	 carboxylates	 accumulated	 at	 higher	 rates	 with	 respect	 to	 the	
control	during	the	stationary	phase	(more	substantially	malate).	Of	note,	some	of	these	
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Figure	4.3	Overview	of	uptake/secretion	rates	in	control	and	asparagine	modulated	cultures,	represented	
in	 units	 of	 nmol/106cells/h.	 For	 asparagine,	 serine,	 pyruvate,	 aspartate,	 glucose	 and	 glutamate,	 a	
positive/negative	 value	 indicates	 consumption/secretion,	 respectively.	 For	 alanine,	 ammonia,	 lactate,	
formate,	glycine,	glycerol,	succinate,	fumarate	and	malate,	a	positive	or	negative	value	indicates	secretion	
or	consumption,	respectively.	The	growth	and	non-growth	phases	of	“Control”	and	“Low	Asn”	cultures	are	











40	 %	 lower	 than	 in	 control	 conditions,	 prompting	 significant	 alterations	 in	 related	
metabolic	 fluxes.	While	 the	production	 rate	of	 formate	decreased	 to	 the	 same	extent,	







As	 in	 the	 early	 asparagine	 exhaustion	 scenario,	 the	 halt	 in	 growth	 upon	 serine	
depletion	suggests	its	essentiality	for	GS-CHO	cells	(Fig.	4.1),	although	asparagine	was	
also	 almost	 depleted	 around	 the	 same	 time.	 The	 ensuing	 metabolic	 state	 was	
characterized	 by	 pronounced	 alterations	 relatively	 to	 the	 control	 stationary	 phase.	
Again,	linked	to	the	consumption	of	aspartate	and	glutamate	was	the	net	production	of	
both	ammonia	and	alanine.	Interestingly,	alanine	production	is	halted	at	around	120	h,	
coinciding	 with	 the	 depletion	 of	 glutamate	 and	 aspartate,	 whereas	 ammonia	 is	
produced	throughout	(Figs.	4.4	and	4.5).	While	glucose	consumption	remained	similar	
to	control	cultures,	the	typical	lactate	production	to	consumption	shift	did	not	occur	in	
serine-depleted	 cultures.	With	 regard	 to	TCA	cycle	 intermediates,	 succinate	 secretion	
was	 halted	 after	 serine	 depletion,	 displaying	 a	 low	 consumption	 rate	 whilst	
maintaining	a	high	production	rate	in	the	control.	This	interesting	observation	parallels	
the	effect	of	asparagine	availability	on	malate	and	fumarate	secretion.	
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Figure	 4.4	 Time	 profiles	 of	 selected	 metabolites	 in	 the	 supernatants	 of	 control	 and	 serine	 modulated	
cultures	(data	from	clone	I).		
4.3.2.2 Cultures	with	low	serine	concentration		
When	 serine	 concentration	 was	 kept	 at	 low	 levels	 by	 daily	 feeding,	 substantial	
differences	 were	 not	 observed	 with	 respect	 to	 the	 control	 in	 terms	 of	 culture	
performance	or	metabolic	behavior,	 except	 for	 a	distinct	 reduction	of	nearly	50	%	 in	
formate	 and	 glycine	 production	 during	 the	 exponential	 phase	 (Figs.	 4.1	 and	 4.5).	
Conversely,	during	the	stationary	phase,	serine	concentration	progressively	 increased	
due	to	consumption	slowdown	(Fig.	4.1C),	resulting	in	higher	secretion	of	formate	and	
glycine	during	 this	phase	 in	 relation	 to	 control	 cultures	 (Fig.	4.5).	On	 the	other	hand,	
succinate	is	consumed	contrasting	with	its	release	in	control	cultures.	As	in	the	case	of	
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asparagine,	 these	 results	 suggest	 that	 serine	 feeding	 should	 be	 tightly	 controlled	 to	
minimize	by-product	formation	and	match	cellular	needs.	
	
Figure	 4.5	Overview	of	uptake/secretion	rates	 in	control	and	serine	modulated	cultures,	 represented	 in	
units	 of	 nmol/106cells/h.	 For	 asparagine,	 serine,	 pyruvate,	 aspartate	 and	 glutamate,	 a	 positive/negative	
value	 indicates	 consumption/secretion,	 respectively.	 For	 alanine,	 ammonia,	 lactate,	 formate,	 glycine	 and	
succinate,	 a	positive	or	negative	value	 indicates	 secretion	or	 consumption,	 respectively.	The	growth	and	
non-growth	 phases	 of	 “Control”	 and	 “Low	 Ser”	 cultures	 are	 from	 0h	 to	 96h	 and	 from	 96h	 to	 168h,	






nutrients	 could	 have	 been	 depleted	 or	 reached	 limiting	 concentrations	 (Fig.	 4.1).	 To	
verify	 this	hypothesis,	 additional	 cultures	were	 tested	using	centrifugation	 to	 remove	
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(which	 in	 CDCHO	medium	 is	 below	 0.5	mM)	 could	 partially	 restore	 cell	 density	 and	
product	 formation	 observed	 in	 the	 absence	 of	 serine	 (Fig.	 4.6A,B).	 Glycine	 is	 a	 key	
intervenient	in	the	generation	of	tetrahydrofolate	(THF)-bound	one-carbon	units	and	is	
synthesized	 through	 the	activity	of	 serine	hydroxymethyl	 transferase.	 Interestingly,	 it	
has	been	 found	 that	some	CHO	cell	mutants	 that	are	glycine	auxotrophs	only	express	
the	cytosolic,	but	not	the	mitochondrial,	version	of	this	enzyme	(Tibbetts	and	Appling,	
2010).	This	suggests	most	glycine	needs	in	the	GS-CHO	clones	here	used	are	fulfilled	by	
serine	 conversion	 in	 the	 mitochondria.	 In	 agreement,	 it	 was	 recently	 reported	 that	
cancer	 cell	 lines	 can	 inter-convert	 serine	 and	 glycine,	 but	 display	 better	 growth	 in	
glycine-free	medium	than	is	serine-free	medium	(Maddocks	et	al.,	2013).	This	is	due	to	
the	 fact	 that	 serine	 conversion	 to	 glycine	 produces	methyl-THF,	whereas	 the	 reverse	
reaction	 inhibits	proliferation	by	depleting	 the	methyl-THF	pool.	At	 the	same	time,	 in	
our	 cultures	 formate	 is	 accumulated	 in	 the	 medium	 as	 a	 by-product	 from	 serine	
consumption,	although	not	reaching	previously	reported	toxic	concentrations	(Ihrig	et	
al.,	 1995).	 Of	 note,	 when	 cells	 are	 cultured	 in	 the	 absence	 of	 serine	 with	 glycine	
supplementation,	formate	secretion	is	negligible	(Fig.	4.6C).		
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To	 further	 evaluate	 pyruvate	 fates	 in	 the	 absence	 of	 asparagine	 or	 serine,	 in	 which	
pyruvate	uptake	is	stimulated,	a	set	of	cultures	was	performed	with	initial	5	mM	serine	
and	asparagine	or	without	 either	amino	acid,	 supplemented	with	pyruvate	 labeled	 in	
the	first	carbon	(1-13C-Pyr).	This	labeled	substrate	allows	to	infer	the	ratio	between	the	
activities	 of	 pyruvate	 dehydrogenase	 (PDH)	 and	 pyruvate	 carboxylase	 (PC):	 in	 the	
former	case,	 the	13C	 label	 is	 lost	to	13CO2	release	without	 integration	in	the	TCA	cycle,	
while	 through	 the	 carboxylation	 reaction	 labeled	 oxaloacetate	 is	 formed	 leading	 to	
appearance	of	13C-intermediates,	as	shown	in	Figure	4.7A.		
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Figure	 4.7A	 Schematic	 of	 carbon	 atom	 transitions	 in	 pyruvate	 metabolism.	 Isotopic	 label	 from	 1-13C-
pyruvate	 is	 lost	 to	 CO2	 while	 entering	 the	 TCA	 cycle	 through	 pyruvate	 dehydrogenase	 (PDH),	 but	 is	
retained	during	the	anaplerotic	carboxylation	to	oxaloacetate	(OAA)	via	pyruvate	carboxylase	(PC).	Black	




addition	 was	 50	 %,	 and	 the	 time	 profiles	 of	 label	 distribution	 in	 intracellular	
metabolites	 during	 the	 ensuing	 60	 min	 are	 shown	 in	 Figures	 4.7B	 and	 4.7C.	
Interestingly,	 different	M1	 labeling	 levels	 of	 lactate	 (10	%)	 and	 alanine	 (40	%)	were	
observed,	 suggesting	 different	 pyruvate	 sub-pools,	 one	 derived	 mainly	 from	 the	
catabolism	of	glucose	and	another	mainly	from	extracellular	pyruvate.	Distinct	labeling	
patterns	 in	 these	 two	 pyruvate-derived	 metabolites	 have	 been	 observed	 in	 other	
mammalian	 cell	 lines	 (Sheikholeslami	 et	 al.,	 2013;	Walther	 et	 al.,	 2012).	 To	better-fit	
experimental	labeling	data,	researchers	have	assumed	the	presence	of	distinct	pyruvate	
pools	 in	 the	 cytosol	 and	 the	 mitochondria,	 with	 alanine	 mainly	 derived	 from	
mitochondrial	 pyruvate	 containing	more	 label	 originated	 from	glutamine,	 and	 lactate	
primarily	generated	from	cytosolic	pyruvate	coming	from	glycolysis.	
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Figure	 4.7B/C	 Time	 profiles	 of	 intracellular	 metabolites	 after	 the	 introduction	 of	 1-13C-pyruvate	 in	
cultures	 of	 clone	 II,	 in	 the	 absence	 of	 (B)	 serine,	 or	 (C)	 asparagine.	 Percentages	 of	 13C-labeled	 mass	
isotopomer	 (M1)	were	 determined	 after	 correction	 for	 natural	 abundances.	 Error	 bars	 depict	 standard	
deviations	 from	two	biological	 replicates.	The	m/z	values	of	M1	 fragment	 ions	are:	 lactate,	261;	alanine,	
260;	aspartate,	418;	malate,	419;	citrate,	591;	glutamate,	432;	glycine,	246;	serine,	390.	
The	pools	of	glutamate	(M1	up	to	6	%)	and	glutamine	(similar;	data	not	shown)	were	
less	 enriched	 than	 aspartate,	 malate	 or	 citrate	 since	 the	 carboxylic	 group	 of	
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we	could	not	observe	labeling	of	succinate	in	any	culture	(data	not	shown),	confirming	
that	the	label	 from	pyruvate	is	 lost	to	CO2	through	clockwise	TCA	cycle	activity,	while	
being	 interrupted	counterclockwise	by	 the	 irreversibility	of	succinate	dehydrogenase.	
After	 the	 initial	 60	 min	 of	 culture,	 the	 fraction	 of	 the	 labeled	 pools	 decreases	 in	 all	
cultures	 for	 all	 intracellular	 metabolites	 (data	 not	 shown).	 This	 is	 due	 to	 the	 much	
higher	uptake	rate	of	glucose	from	the	culture	medium,	each	molecule	generating	up	to	




metabolites	 analyzed	 (Fig.	 4.7B,C).	 Aspartate,	 malate	 and	 citrate	 pools	 were	
significantly	 labeled,	 indicating	 activity	 through	 PC,	 in	 agreement	 with	 recent	 works	
(Ahn	 and	 Antoniewicz,	 2011;	 Dean	 and	 Reddy,	 2012;	 Templeton	 et	 al.,	 2013).	
Considering	the	40	%	M1	labeling	of	alanine	and	the	20	%	of	malate	or	aspartate,	we	
can	estimate	that	the	PC/PDH	ratio	is	approximately	1.	The	channeling	of	pyruvate	into	
the	 TCA	 cycle	 during	 the	 initial	 growth	 period	 of	 a	 DHFR-CHO	 cell	 line	 was	 also	
reported	 to	 have	 similar	 fluxes	 through	 PC	 and	 PDH	 (Templeton	 et	 al.,	 2013).	 More	
interestingly,	 we	 observed	 that	 both	 serine	 and	 glycine	 pools	 displayed	 15	 %	 M1	
labeling	 1h	 after	 1-13C-pyruvate	 addition	 in	 cultures	 without	 serine,	 strongly	
contrasting	with	the	minor	fraction	labeled	(~3	%)	in	serine	containing	medium.	This	
confirms	 that	 the	 serine	 synthesis	 pathway	 is	 activated	 under	 serine	 starvation	
conditions.	 The	 capability	 of	 several	 cancer	 cell	 lines	 to	 synthesize	 serine	 during	 the	
proliferative	phase	has	previously	been	reported	(Ye	et	al.,	2012	and	Maddocks	et	al.,	
2013),	but	 in	 these	studies	 labeled	serine	was	derived	 from	glucose.	As	 the	glycolytic	
reaction	 catalyzed	 by	 pyruvate	 kinase	 is	 irreversible,	 the	 appearance	 of	 label	 into	
serine	 and	 glycine	 coming	 from	 pyruvate	 in	 our	 study	 indicates	 activity	 through	
phosphoenolpyruvate	carboxykinase	(PEPCK)	upon	processing	through	PC	(Fig.	4.7A).	
The	 role	 of	 PEPCK	 in	 serine	 synthesis	 from	 pyruvate	 has	 been	 recently	 highlighted	
(Kalhan	 et	 al.,	 2011;	 Kalhan	 and	 Hanson	 2012);	 tracer	 isotopic	 studies	 in	 rat	




In	 cultures	 without	 asparagine,	 the	 fraction	 of	 13C-labeled	 TCA	 cycle	 intermediates	
(malate	and	citrate),	as	well	as	aspartate	and	glutamate	was	consistently	higher	than	in	
control	 cultures	 (Fig.	 4.7B,C).	 This	 indicates	 that	 the	 higher	 uptake	 flux	 of	 pyruvate	




of	 the	 cultures	 performed,	 suggesting	 that	 these	 cells	 do	 not	 synthesize	 asparagine	
even	under	 starvation	 conditions.	While	negligible	 asparagine	 synthetase	 activity	has	
been	 recently	 reported	 in	 DHFR-CHO	 cell	 lines	 by	 Dean	 and	 Reddy	 (2013),	
Fomina-Yadlin	et	al.	(2013)	showed	the	upregulation	of	transcript	and	protein	levels	of	
this	 enzyme	 following	 asparagine	 withdrawal	 in	 different	 parental	 and	
antibody-producing	 CHO	 cell	 lines,	 but	 growth	 suppression	 was	 still	 observed.	
Interestingly,	in	an	earlier	study,	CHO	cells	could	be	adapted	to	grow	in	asparagine-free	
medium	with	increased	uptake	of	other	amino	acids	(Seewooster	and	Lehmann,	1995).	
Overall,	 it	 seems	 the	 dependency	 on	 asparagine	 for	 growth	 and	 the	 ability	 for	 its	de	




their	 essentiality	 and	 effect	 on	 cell	 physiology,	 namely	 their	 inter-relationships	 in	
nitrogen	and	carbon	metabolism,	biosynthesis	and	the	impact	on	culture	performance.	
Asparagine	was	confirmed	as	essential	for	growth	and	the	main	source	of	intracellular	
nitrogen	 and	 related	 alanine	 and	 ammonia	 formation.	Moreover,	 the	 results	 revealed	
an	 interconnection	 between	 asparagine	 uptake	 and	 the	 flux	 of	 pyruvate	 in	 order	 to	
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maintain	 TCA	 cycle	 flux	 for	 biosynthesis	 and	 energy	 generation	 through	 increased	
anaplerotic	 PC	 activity.	 On	 the	 other	 hand,	 serine	 limitation	 activated	 its	 synthesis	
pathway,	but	also	affected	cell	growth	as	well	as	the	production	of	glycine	and	formate,	
highlighting	 the	 involvement	 in	 the	metabolism	 of	 one-carbon	 units	 linked	 to	 purine	
biosynthesis	and	essential	in	methylation	reactions.	Interestingly,	although	asparagine	
and	 serine	 have	 distinct	metabolic	 roles,	 their	 respective	 limitation	 triggered	 the	 up	
regulation	 of	 the	 consumption	 of	 the	 other,	 suggesting	 a	 compensatory	 mechanism.	
Furthermore,	 both	 amino	 acids	 were	 related	 to	 the	 production	 of	 specific	 TCA	 cycle	
intermediates,	namely	malate	and	fumarate	associated	with	asparagine,	and	succinate	
associated	with	 serine.	 Finally,	 the	 results	presented	 suggest	 that	 feeding	 schemes	of	
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The	 focus	of	 this	 thesis	was	 the	characterization	of	 the	GS-CHO-K1	cell	metabolism,	a	
mammalian	 cell	 line	 that	 is	 widely	 adopted	 by	 the	 industry	 for	 the	 production	 of	
blockbuster	 biologics.	 The	 experimental	 approach	 was	 based	 on	 the	 comparison	 of	
cellular	 phenotypes	 under	 different	 productive	 states,	 either	 cell	 clones	 expressing	
different	 amounts	 of	 the	 same	 recombinant	 protein,	 cultured	 with	 or	 without	
productivity	 enhancers.	 The	 analysis	 of	 these	 scenarios	 enabled	 the	 identification	 of	
culture	 and	 cellular	 parameters	 that	 govern	 productivity,	 and	 to	 hypothesize	 new	
strategies	in	order	to	improve	process	performance.		
Bioprocess	development	based	on	empirical	knowledge	and	inefficient	trial-and-error	
experiments	 to	 select	 ideal	 culture	 conditions	 to	 produce	 recombinant	 proteins	 has	
been	 evolving	 towards	 more	 balanced	 approaches.	 In	 the	 post-genomic	 era,	 Omics	
technologies	 allow	 us	 to	 holistically	 analyse	 cell	 components	 and	 study	 their	
interactions	 to	 then	 fully	 exploit	 the	 cell	 potential	 in	 the	 production	 of	 high-value	
biopharmaceuticals.	 While	 the	 fields	 of	 genomics	 and	 transcriptomics	 have	 had	
important	contributions	for	cell	line	and	bioprocess	development,	metabolomics	is	still	





adopted,	where	 the	most	 simple	 application	 takes	 only	metabolite	 transport	 rates	 as	
experimental	 data	 and	 balances	 them	 in	 the	metabolic	 network	 in	 order	 to	 estimate	
intracellular	fluxes	(Quek	et	al.	2010).		Flux	resolution	can	be	further	improved	using	of	
isotopic	tracers	coupled	with	MFA.	Several	studies	have	shown	that	a	careful	choice	of	
labelled	 tracers	 is	 essential	 to	 achieve	 optimal	 flux	 resolution	 of	 specific	 pathways	
(Crown	and	Antoniewicz	2012;	Metallo	et	 al.	2009).	Thus,	 the	use	of	 specific	 isotopic	
tracers	 became	 a	 fundamental	 method	 in	 this	 work	 allowing	 increasing	 metabolic	
network	 resolution	 and	 the	 precision	 necessary	 to	 distinguish	 metabolic	 activity	
through	cyclic	and	parallel	pathways.	This	way	it	was	possible	to	estimate	the	recycling	
of	 phosphates	 between	 PPP	 and	 glycolysis,	 and	 to	 investigate	 the	 bridge	 between	
glycolysis	and	TCA	cycle	(PC,	PDH	and	ME	activities)	under	different	culture	conditions.	
The	 main	 aims,	 approaches	 followed,	 major	 outcomes	 and	 suggestions	 for	 future	
studies	based	on	the	outcomes	of	this	thesis	are	summarized	in	Figure	5.1.	




We	 initially	 compared	 the	metabolism	of	 two	GS-CHO	 cell	 clones	 producing	different	
levels	of	an	IgG4	(the	productivity	per	cell	is	2.5-fold	different	between	clones).	1H-NMR	
spectroscopy	of	the	cell	culture	supernatant	allowed	the	quantification	of	an	extensive	
number	 of	 metabolites	 over	 time.	 Besides	 the	 main	 substrates	 (glucose	 and	 amino	
acids)	 and	 lactate,	 usually	 analyzed	 in	 mammalian	 cell	 cultures,	 it	 was	 possible	 to	
quantify	pyruvate,	 acetate,	 the	phospholipid	precursor	 choline,	 as	well	 as	 several	 by-
products	 (Chapter	 2). From	 this	 analysis	 we	 observed	 that	 in	 batch	 cultures,	 the	
depletion	 of	 asparagine	 coincides	with	 the	 start	 of	 the	 stationary	 phase.	 Glucose	 and	
serine	 were	 also	 almost	 depleted	 by	 the	 end	 of	 the	 stationary	 phase.	 The	 ability	 to	
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method	 for	rational	media	design.	As	a	 first	approach	to	 tackle	 the	depletion	of	 these	
nutrients,	 a	 strategy	 based	 on	 a	 bolus-feeding	 containing	 the	 limiting	 nutrients	 was	




We	 constructed	 a	 GS-CHO-K1	 metabolic	 network,	 including	 117	 reactions	 and	 83	
balanced	metabolites,	 to	contextualize	the	exometabolome	data,	and	estimate	by	MFA	
in	 vivo	 fluxes	 in	 the	 low	 and	 high	 producer	 clones.	 Despite	 the	 difference	 in	 specific	
productivities	 between	 clones	 (about	 2.5-fold),	 they	 exhibited	 minor	 metabolic	
differences	 in	 the	 estimated	 fluxes.	 This	 might	 be	 explained	 in	 part	 by	 the	 low	
resolution	 of	 the	 estimated	 fluxomes	 of	 each	 clone.	 These	 cultures	 were	 conducted	
without	 resorting	 to	 labelled	 substrates,	 which	 prevented	 discriminating	 the	 fluxes	
through	parallel/cyclic	pathways	and	reversible	reactions.	
The	 quest	 for	 improved	 production	 of	 complex	 biologics	 in	 CHO	 cells	 has	 been	
accompanied	 by	 attempts	 to	 improve	metabolic	 efficiency,	mainly	 the	 channelling	 of	
glucose-derived	carbons	 from	glycolysis	 into	 the	TCA	cycle,	avoiding	 the	 formation	of	
by-products	 (e.g.	 lactate)	while	maximizing	 the	ATP	produced	per	glucose	consumed.	
Therefore,	 one	 approach	 to	 improve	 the	 efficiency	 of	 CHO	 cells	 has	 been	 through	
altering	 energy	metabolism	 by	 controlling	 glucose	 concentration,	 keeping	 it	 at	 levels	
that	sustain	cell	proliferation	and	maintenance	but	limit	the	amount	of	glucose-derived	
undesired	 by-products	 (Dean	 and	 Reddy	 2013;	 Kim	 et	 al.	 2012).	 However,	 this	
approach	 needs	 to	 be	 fine-tuned	 otherwise	 it	 might	 have	 a	 negative	 impact	 on	 the	
glycosylation	 patterns	 of	 antibodies	 produced	 in	 CHO	 cells	 (Liu	 et	 al.	 2014).	 For	
instance,	 Seo	 and	 co-workers	 (2014)	 observed	 aglycosylated	 antibodies	 in	 fed-batch	
cultures	 of	 a	 human	 cell	 line	 (F2N78)	 when	 glucose	 was	 depleted	 or	 exhibited	 high	
ammonia	 accumulation.	 Thus,	 a	 balanced	 stoichiometric	 feeding	 can	 significantly	
increase	cell	viability,	reduce	by-product	 formation	and	improve	glycosylation	quality	
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(Xie	 et	 al.	 1997).	 Several	 cell	 engineering	 approaches	 have	 also	 been	 conducted	 to	
improve	 the	 metabolic	 efficiency	 of	 CHO	 cells,	 in	 particular	 the	 down-regulation	 of	
specific	genes	to	reduce	lactate	formation	(Chen	et	al.	2001;	Kim	and	Lee	2007).		
Nevertheless,	in	the	cancer	metabolism	field	the	most	accepted	explanation	for	the	high	
lactate	 secretion	 rate	 despite	 plenty	 of	 oxygen	 availability	 (Warburg	 effect),	 suggests	
that	it	better	serves	the	anabolic	demands	of	rapidly	proliferating	cells	(Vander	Heiden	
et	 al.	 2009).	 Although	 ATP	 generation	 from	 glycolysis	 is	 much	 less	 efficient	 than	
oxidative	metabolism,	 producing	 only	 two	 ATP	molecules	 compared	with	 36	 for	 the	
complete	 oxidation	 of	 glucose,	 lactate	 production	 allows	 glycolysis	 to	 be	 accelerated	
because	 the	 conversion	 of	 pyruvate	 to	 lactate	 recycles	 the	 NAD+	 necessary	 for	
glycolysis.	 Rather	 than	 undergoing	 complete	 oxidation	 to	 CO2	 and	 water	 in	 the	 TCA	
cycle,	 the	 partial	 conversion	 of	 glucose	 into	 lactate	 allows	 more	 glycolytic	
intermediates	 upstream	 to	 pyruvate	 to	 be	 available	 for	 the	 biosynthesis	 of	 cellular	
building	 blocks	 (nucleic	 acids,	 amino	 acids,	 and	 fatty	 acids),	 which	 are	 required	 for	
proliferation.	 This	 might	 explain	 why	 the	 down-regulation	 of	 lactate	 production	 has	
allowed	only	marginal	improvements	in	cell	culture	performance.		
	
The	 manipulation	 of	 energy	 metabolism	 in	 mammalian	 cells	 has	 moved	 beyond	
controlling	 glucose	 and	 glutamine	 concentrations	 towards	 the	 analysis	 of	 the	
contributions	of	 	 several	 amino	 acids	 and	 their	 interactions	with	 cellular	metabolism	
(Zhou	 et	 al.	 1997).	 In	 the	 work	 presented	 in	 this	 thesis,	 further	 investigations	 were	
made	into	the	amino	acid	metabolism	that	differentiates	GS-CHO	cells	from	other	CHO	
cell	 lines.	 GS-CHO	 cells	 can	 synthetize	 glutamine	 above	 endogenous	 levels,	 allowing	
them	to	thrive	in	a	glutamine-free	media.	Through	modulations	of	asparagine	we	found	
that	 this	 amino	 acid	 was	 the	 main	 nitrogen	 source	 for	 the	 cell	 and	 used	 for	 energy	
generation	 in	 the	 TCA	 cycle,	 essential	 for	 cell	 growth	 (Chapter	 4).	 Additionally,	
asparagine	 and	 serine	were	 associated	with	 the	production	 of	 by-products,	 including	
not	 only	 ammonia	 but	 also	 formate,	 alanine	 or	 glycine.	 These	 results	 suggest	 that	
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feeding	 strategies	 can	 be	 designed	 and	 fine-tuned	 in	 order	 to	 minimize	 by-product	
formation,	while	maintaining	biosynthesis	requirements.		
5.1.2 Advantages	of	using	isotopic	tracers	




more	 realistic	 representation	 of	 in	 vivo	 cellular	 metabolism	 (Ahn	 and	 Antoniewicz	
2011;	Niklas	and	Heinzle	2012).		
In	 this	work,	we	 used	 [1,2-13C]-glucose	 to	 characterize	 the	 flux	 partitioning	 between	
glycolysis	 and	 pentose	 phosphate	 pathways	 (Chapter	 3)	 in	 exponentially-growing	
cultures	 of	 the	 high	 producer	 clone.	 Importantly,	 it	 was	 possible	 to	 quantify	 PPP	
activity,	rendering	up	to	30%	of	all	glucose-derived	carbons,	as	70%	continued	directly	
throughout	 glycolysis.	 This	 is	 particularly	 relevant	 as	 non-oxidative	 PPP	 activity	 is	
often	 described	 as	 negligible	 during	 exponential	 phase	 in	 the	 literature	 (Ahn	 and	
Antoniewicz	 2011).	 Additionally,	 a	 high	 cycling	 activity	 between	 PPP	 and	 glycolysis	
was	demonstrated	by	the	abundance	of	heavier	isotopomers.	Unfortunately,	due	to	the	
high	costs	associated	to	cultures	with	labelled	substrates	and	MS	analysis,	we	could	not	
compare	 the	 fate	 of	 labelled	 glucose	 between	 the	 low	 and	 high	 producer	 clones.	 It	
would	 be	 of	 interest	 to	 quantify	 this	 feature	 in	 the	 low	 producer	 clone	 as	 well	 to	
investigate	its	correlation	with	productivity.	
As	stated	before,	the	estimation	of	 fluxes	through	parallel	and	cyclic	pathways	cannot	
be	 resolved	without	 the	use	 of	 labelled	 tracers.	Goudar	 et	 al	 (2010)	 showed	 that	 the	
lack	of	isotopic	tracer	information	does	not	have	a	significant	impact	on	most	fluxes	in	
the	 network,	 but	 estimations	 obtained	 through	 classical	 MFA	 and	 13C-MFA	 only	
matched	when	ox-PPP	fluxes	and	PC	activity	were	fixed	at	the	values	obtained	through	
13C-MFA.	 Bonarius	 et	 al	 (1996)	 had	 quite	 different	 results	 while	 using	 the	 two	
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techniques	 to	 estimate	metabolic	 fluxes	 in	 hybridoma	 cells	 at	 different	 physiological	
states:	 using	 classical	 MFA	 (without	 the	 use	 of	 labelled	 tracers)	 90%	 of	 all	 glucose-
derived	 carbons	 were	 estimated	 to	 go	 through	 PPP	 instead	 of	 only	 20%	 when	
calculated	 through	 13C-MFA.	 These	 contrasts	 translate	 the	 potential	 of	 using	 labelled	
tracers	in	order	to	deepen	our	knowledge	of	net	fluxes	in	the	CHO	metabolic	network.	
We	 also	 used	 fully-labelled	 (13C	 and	 15N)	 asparagine	 and	 fully-labelled	 serine	 to	
investigate	further	the	fate	of	these	two	amino	acids	in	GS-CHO	cells.	This	way,	 it	was	
possible	to	confirm	asparagine	and	serine	as	important	nitrogen	sources,	fuelling	other	
amino	 acids	 and	 TCA	 cycle	 intermediates.	 Using	 1-13C-pyruvate	 it	 was	 possible	 to	
distinguish	 the	 fate	 of	 pyruvate	 in	 case	 of	 asparagine	 or	 serine	 unavailability	 –	
conditions	 which	 dramatically	 increased	 pyruvate	 uptake	 rates	 (Chapter	 4).	 This	
allowed	 us	 to	 differentiate	 the	 activities	 of	 PC	 and	 PDH,	 both	 sharing	 50%	 of	 the	
metabolic	 fluxes	 derived	 from	 pyruvate	 into	 the	 TCA	 cycle.	 Therefore,	 pyruvate	
carboxylase	is	also	an	important	anaplerotic	route	in	these	cells.	The	lack	of	asparagine	





et	 al.	 2007).	 We	 can	 anticipate	 that	 the	 use	 of	 labelled	 tracers	 and	 metabolic	 flux	




of	 histones,	 and	 these	 alterations	 favour	 higher	 transcription	 rates	 (Kruh	 1982;	
Palermo	et	al.	1991).	Moreover,	it	has	been	shown	that	butyrate	interrupts	cell	cycle	at	
G1	phase,	where	protein	synthesis	could	be	highest	(Kruh	1982).	Rapid	improvements	
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in	protein	production,	avoiding	time-consuming	and	 laborious	gene	amplification	and	
cell	 engineering	 steps,	 explains	 butyrate	 application	 in	 industry.	 Furthermore,	 it	 has	
been	 shown	 that	 butyrate	 does	 not	 compromise	 glycosylation	 of	 recombinant	
antibodies,	while	it	may	alter	sialic	acid	content	(Mimura	et	al.	2001;	Sung	et	al.	2004).		




consumption	 throughout	 culture	 time	 (Chapter	 2).	 Additionally,	 butyrate	 treatment	
seems	 to	 induce	 an	 increased	 malate-pyruvate	 cycle	 activity,	 revealed	 by	 the	 use	 of	
isotopic	tracers	(Chapter	4).	Importantly,	it	could	compensate	for	insufficient	pyruvate	
transport	from	the	cytosol	into	the	mitochondria	that	might	limit	the	energetic	capacity	
of	 GS-CHO	 cells.	 The	 interaction	 between	 cytosolic	 glycolysis	 and	mitochondrial	 TCA	
cycle	is	a	well	known	bottleneck	in	production	processes	and,	despite	being	pivotal	in	
metabolism,	 the	 control	mechanisms	 remain	 rather	 unknown	 (Wahrheit	 et	 al.	 2014).	
These	results	point	out	the	need	to	further	clarify	these	mechanisms	surrounding	this	
metabolic	 hub,	 possibly	 through	 enzymatic	 studies	with	 the	 capability	 to	 distinguish	
cellular	 compartments.	Moreover,	 the	 evaluation	 on	 how	 the	 availability	 of	 pyruvate	
may	 limit	 the	 performance	 of	 high	 producing	 clones	 seems	 to	 be	 crucial	 to	 further	
detail	the	interconnectivity	between	such	metabolic	pathways.	
Interestingly,	 CHO	 cells	 under	 butyrate	 treatment	 conditions	 presented	 also	 an	
increase	of	2.5-fold,	in	average,	in	intracellular	metabolite	pools	through	glycolysis,	PPP	
and	 TCA	 cycle	 intermediates,	 fitting	 well	 with	 the	 observation	 that	 butyrate-treated	
cells	were	in	fact	larger	and	with	higher	dry	cell	weights	measured.	Glutamine	was	the	
metabolite	with	 highest	 difference	 in	 intracellular	metabolite	 pools	 at	 around	 4-fold,	
which	correlates	well	with	the	hypothesis	that	butyrate	allows	higher	expression	levels	
of	glutamine	synthetase,	in	addition	to	the	genes	of	interest,	as	discussed	in	Chapter	3.		
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5.2 Outlook	for	future	research	
At	 the	 moment,	 our	 group	 is	 working	 on	 the	 data	 obtained	 from	 parallel	 labelling	
experiments	 using	 different	 isotopic	 tracers	 to	 be	 integrated	 into	 a	 single	 model	
allowing	 the	 comparison	 of	 the	 fluxome	 of	 GS-CHO	 cells	 with	 different	 productive	
phenotypes.	 It	 is	 expected	 that	 the	 result	 from	 this	 comparison	 will	 reveal	 insights	
about	 the	 metabolism	 that	 may	 allow	 media	 design	 optimization,	 also	 providing	
important	clues	for	process	and	cell	engineering	strategies.	
Future	efforts	 should	be	directed	 towards	 the	 incorporation	of	 compartmentalization	
in	metabolic	models.	 The	 regulation	of	 energy	metabolism	 is	 intimately	 connected	 to	
the	 structural	 organization	 of	 the	 cells.	 Several	 studies	 have	 revealed	 that	molecular	
overcrowding	 restricts	 the	 mobility	 of	 large	 and	 small	 molecules	 inside	 the	 cells,	
impacting	cellular	features	such	as	the	intracellular	diffusion	of	ATP	or	the	transport	of	
metabolites	 across	 different	 compartments	 (Ovádi	 and	 Saks	 2004).		
Compartmentalization	 can	 be	 also	 a	 hurdle	 to	 the	 analysis	 of	 metabolic	 fluxes,	
increasing	the	number	of	alternative	pathways,	reversible	transport	reactions	and	the	
number	 of	 degrees	 of	 freedom.	 Nevertheless,	 the	 ability	 to	 separately	 measure	
metabolite	concentrations	in	different	intracellular	compartments	remains	a	bottleneck	
(Wahrheit	et	al.	2011).	The	metabolome	is	the	cellular	information	layer	which	quicker	
responds	 to	 perturbations;	 changes	 in	 the	 concentration	 of	metabolites	 can	 occur	 in	
seconds.	Therefore,	efficient	separation	of	compartments	before	metabolite	analysis	is	
technically	 complex.	 Alternative	 approaches	 must	 be	 developed	 to	 deal	 with	 this	
challenge.	 For	 instance,	 Lewis	 et	 al	 (2014)	 proposed	 to	 trace	 hydrogen	 in	
compartmentalized	 reactions	 that	 use	 NADPH	 as	 a	 cofactor,	 allowing	 to	 discern	
metabolic	pathway	activity	in	both	the	cytosol	and	the	mitochondria.		
MS-based	metabolomics	 approaches	 are	 in	 expansion	 allowing	 to	 uncover	metabolic	
bottlenecks	 for	 recombinant	 protein	 production	 in	 CHO	 cells.	 A	 big	 step	 in	 this	
direction	was	recently	given	by	Link	and	coworkers	(2015);	these	authors	developed	a	
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method	 for	 real-time	 metabolome	 profiling	 using	 high-resolution	 MS,	 which	 allows	
measuring	the	dynamic	behavior	of	300	metabolites	upon	a	perturbation.	
Integration	of	 all	 levels	of	Omics	data	 is	 a	priority	 towards	a	global	understanding	of	
any	 biological	 system	 (Lewis	 et	 al.	 2016).	 Little	 effort	 has	 been	 done	 so	 far	 on	 the	
simultaneous	 integration	 of	 the	 information	 from	 the	 genome,	 transcriptome,	
proteome	 and	 metabolome.	 Genome-scale	 models	 (GEMs)	 that	 aim	 to	 provide	 a	
comprehensive	 representation	 of	 the	 link	 between	 genotype	 and	 phenotype,	 while	
integrating	 data	 from	 all	 Omics	 layers	 have	 started	 to	 be	 developed	 for	 mammalian	
cells.	 These	 models	 include	 a	 collection	 of	 all	 known	metabolic	 processes,	 involving	
metabolites,	 enzymes	 catalysing	 each	 reaction	 and	 the	 genes	 that	 code	 for	 the	
machinery	 required	 in	 these	 processes.	 Moreover,	 these	 models	 aim	 to	 accurately	
predict	 cellular	behavior	 in	 culture,	 including	 growth	 rates,	 auxotrophies	of	 cell	 lines	
and	 production	 titres.	 Quek	 et	 al	 (2014)	 used	 Recon	 2,	 the	 human	 genome-scale	
metabolic	 network	 (Thiele	 et	 al.	 2013),	 for	 the	metabolic	 characterization	 of	 Human	
Embryonic	 Kidney	 (HEK)	 cells	 when	 L-alanyl-L-glutamine	 dipeptide	 was	 depleted.	
These	 genome-scale	 models	 have	 been	 developed	 also	 for	 Saccharomyces	 cerevisiae,	
Pichia	 pastoris,	 as	 well	 as	 Mus	 musculus,	 for	 industrial,	 medical	 and	 drug	 design	
applications	 (Gutierrez	 and	 Lewis	 2015).	With	 the	 recent	 publication	 of	 several	 CHO	
genomes,	a	specific	GEM	for	CHO	cells	can	now	be	reconstructed	(Lewis	et	al.	2013;	Xu	
et	al.	2011).		
Next	 generation	 sequencing	 is	 stimulating	 a	 genomic	 revolution	 in	 how	 we	 can	
approach	the	issue	of	productivity	improvements	(Kremkow	et	al.	2015;	Monger	et	al.	
2015).	These	advances	will	enable	the	modification	of	target	DNA	sequences	and	thus	
overcoming	 limitations	 imposed	 by	 secretory	 pathways	 or	 inefficient	 nutrient	
metabolism	 (Wurm	 and	 Hacker	 2011).	 Likewise,	 the	 availability	 of	 the	 CHO	 genome	
sequence	 has	 allowed	 to	 use	 microRNAs	 for	 regulating	 gene	 expression.	 Through	
miRNA	binding	to	specific	mRNA	sequences	in	the	host	cell	it	will	be	possible	to	impact	





conditions	 that	 induce	 enhanced	 productivities	 (optimal	 temperature,	 pH	 or	 osmotic	
pressure,	 butyrate	 exposure,	 feeding	 strategies),	 common	 features	 of	
hyperproductivity	 are	 starting	 to	 be	 unveiled.	 These	 features	 are	 being	 revealed	
through	 several	 Omics	 levels,	 among	 four	 main	 functions:	 growth	 control,	 energy	
metabolism,	 redox	 balance	 and	 protein	 secretion	 (Seth	 et	 al.	 2007).	 Instead	 of	 a	 few	




Over	 the	 last	 three	 decades	 typical	 antibody	 titers	 obtained	 in	 bioreactors	 have	
increased	 by	 up	 to	 100-fold.	 Further	 advances	 will	 depend	 upon	 improved	
understanding	 of	 metabolic	 flux	 regulation	 in	 producer	 cell	 lines,	 to	 provide	 the	
environmental	 and	 genetic	 conditions	 favourable	 to	 high	 product	 titer	 and	 quality.	
Resorting	 to	 complementary	 analytical	 techniques	 based	 on	 NMR	 and	 MS,	 isotopic	
tracer	 studies	 and	MFA	modeling	 approaches,	 the	work	 developed	 in	 this	 thesis	 is	 a	
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#	 Reversilibity	 Reaction	 Measured	
	 	 Glycolysis	 	
1	 0	 Glc+ATP=G6P+ADP	 yes	
2	 -1	 G6P=F6P	 no	
3	 0	 F6P+ATP=DHAP+GAP+ADP	 no	
4	 -1	 DHAP=GAP	 no	
5	 -1	 GAP+NAD+ADP=3PG+NADH+ATP	 no	
6	 0	 3PG+ADP=Pyr+ATP	 no	
	 	 TCA	cycle	 	
7	 0	 Pyr+NAD+CoASH=AcCoA+CO2+NADH	 no	
8	 0	 AcCoA+Oxal=Cit+CoASH	 no	
9	 0	 Cit+NAD(P)=αKG+CO2+NAD(P)H	 no	
10	 0	 αKG+CoASH+NAD=SucCoA+CO2+NADH	 no	
11	 -1	 SucCoA+GDP=Succ+GTP+CoASH	 no	
12	 -1	 Succ+FAD=Fum+FADH2	 no	
13	 -1	 Fum=Mal	 no	
14	 -1	 Mal+NAD=Oxal+NADH	 no	
	 	 Pyruvate	fates	 	
15	 -1	 Pyr+NADH=Lac+NAD	 yes	
16	 -1	 Pyr+Glu=Ala+αKG	 no	
	 	 Pentose	Phosphate	Pathway	 	
17	 0	 3G6P+6NADP=3CO2+3R5P+6NADPH	 no	
	 	 Anaplerotic	Reaction	 	
18	 -1	 Mal+NAD(P)=Pyr+HCO3+NAD(P)H	 no	
	 	 Amino	Acid	Metabolism	 	
19	 -1	 Glu+NAD(P)=αKG+NH4+NAD(P)H	 no	
20	 -1	 Oxal+Glu=Asp+αKG	 no	
21	 -1	 Gln+ADP=Glu+ATP+NH4	 no	
22	 0	 Thr+NAD+CoASH=Gly+NADH+AcCoA	 no	
23	 -1	 Ser+THF+NADP=Gly+NADPH+N10FTHF	 no	
24	 -1	 N10FTHF+ADP=ATP+Formate+THF	 yes	
25	 0	 Ser=Pyr+NH4	 no	
26	 0	 Thr=	αKb+NH4	 no	
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27	 0	 αKb+CoASH+NAD+HCO3+ATP=SucCoA+ADP+NADH+CO2	 no	
28	 0	 Trp=Ala+2CO2+αKa	 no	
29	 0	 Lys+2αKG+3NAD(P)+FAD=αKa+2Glu+3NADPH+FADH2	 no	
30	 0	 αKa+2CoASH+2NAD=2AcCoA+2NADH+2CO2	 no	
31	 0	 Val+αKG+CoASH+NAD=IsobutCoA+Glu+CO2+NADH	 no	
32	 0	 IsobutCoA+FAD+2NAD+HCO3+ATP=SucCoA+ADP+FADH2+2NADH+CO2	 no	
33	 0	 IsobutCoA=Isobut	 yes	
34	 0	 Ile+αKG+2CoASH+2NAD+FAD+HCO3+ATP=AcCoA+SucCoA+ADP+Glu+CO2+2NADH+FADH2	 no	
35	 0	 Leu+αKG+CoASH+NAD=IsovalCoA+Glu+CO2+NADH	 no	
36	 0	 IsovalCoA+FAD+ATP+CO2+SucCoA+CoASH=3AcCoA+Succ+FADH2+ADP	 no	
37	 0	 IsovalCoA=Isoval	 yes	
38	 0	 Phe+NADH=Tyr+NAD	 no	
39	 0	 Tyr+αKG+SucCoA+CoASH=Fum+2AcCoA+Succ+Glu+CO2	 no	
40	 0	 Met+Ser+ATP=αKb+NH4+AMP	 no	
41	 -1	 Asn=Asp+NH4	 no	
42	 -1	 Pro+NAD(P)=Glu+NAD(P)H	 no	
43	 0	 Arg+αKG+NAD(P)=2Glu+NAD(P)H+Urea	 no	
44	 0	 His=Glu+NH4	 no	
	 	 Glycogen	Synthesis	 	
45	 0	 G6P=G1P	 no	
46	 0	 G1P+UMPRN+2ATP=UDPG+2ADP	 no	
47	 0	 UDPG=Glycogen+UDP	 no	
	 	 Nucleotide	Synthesis	 	
48	 0	 R5P+ATP=PRPP+AMP	 no	
49	 0	 PRPP+2Gln+Gly+Asp+5ATP+CO2+2N10FTHF=IMP+2Glu+Fum+5ADP+2THF	 no	
50	 0	 IMP+Asp+GTP=AMPRN+Fum+GDP	 no	
51	 0	 IMP+Gln+ATP+NAD=GMPRN+Glu+AMP+NADH	 no	
52	 0	 HCO3+NH4+Asp+2ATP+NAD=Orotate+2ADP+NADH	 no	
53	 0	 Orotate+PRPP=UMPRN+CO2	 no	
54	 0	 UMPRN+Gln+ATP=CMPRN+Glu+ADP	 no	
55	 0	 AMPRN=dAMP	 no	
56	 0	 GMPRN=dGMP	 no	
57	 0	 CMPRN=dCMP	 no	
58	 0	 UMPRN=dTMP	 no	
	 	 Lipid	Synthesis	 	
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59	 0	 Choline+ATP=Pcholine+ADP	 no	
60	 0	 Pcholine+18AcCoA+Glyc3P+22ATP+33NADH=PC+16ADP+6AMP+33NAD	 no	
61	 -1	 PC+Ser=PS+Choline	 no	
62	 0	 PS=PE+CO2	 no	
63	 -1	 Choline+Glyc3P=Glyc3PC	 no	
64	 0	 G6P=Inositol	 no	
65	 0	 Inositol+18AcCoA+Glyc3P+22ATP+33NADH=PI+16ADP+6AMP+33NAD	 no	
66	 0	 18AcCoA+2Glyc3P+22ATP+33NADH=PG+16ADP+6AMP+33NAD	 no	
67	 0	 2PG=DPG+Glyc	 no	
68	 0	 16AcCoA+Ser+Choline+16ATP+29NADPH=SM+2CO2+14ADP+2AMP+29NADP	 no	
69	 0	 18AcCoA+18ATP+14NADPH=Cholesterol+9CO2+18ADP+14NADP	 no	










	 	 Other	by-products	 	
71	 -1	 AcCoA+AMP=Acetate+CoASH+ATP	 yes	
72	 -1	 DHAP+NADH=Glyc3P+NAD	 no	
73	 -1	 Glyc3P=Glyc	 no	
	 	 IgG	Glycosylation	 	
74	 -1	 UDPG=UDPGal	 no	
75	 0	 Glc+ATP+GTP=GDPMann+ADP	 no	
76	 0	 F6P+Gln+AcCoA+UTP=UDPNAG+Glu+CoASH	 no	
77	 0	 UDPNAG+ATP+3PG+CTP=CMPSialic+UDP+ADP	 no	
78	 0	 GDPMann+NADPH=GDPFuc+NADP	 no	








	 	 Transport	Reactions	 	
80	 -1	 =Asp	 yes	
81	 -1	 Gly=	 yes	
82	 -1	 =Ser	 yes	
83	 -1	 =Glu	 yes	




84	 -1	 =Tyr	 yes	
85	 -1	 Ala=	 yes	
86	 -1	 =Arg	 yes	
87	 -1	 =Asn	 yes	
88	 -1	 =Gln	 yes	
89	 0	 =His	 yes	
90	 0	 =Ile	 yes	
91	 0	 =Leu	 yes	
92	 0	 =Lys	 yes	
93	 0	 =Met	 yes	
94	 0	 =Phe	 yes	
95	 -1	 =Pro	 yes	
96	 0	 =Thr	 yes	
97	 0	 =Trp	 yes	
98	 0	 =Val	 yes	
99	 -1	 =Choline	 yes	
100	 -1	 NH4=	 yes	
101	 0	 CO2=	 no	
102	 -1	 Cit=	 yes	
103	 -1	 Fum=	 yes	
104	 -1	 Pyr=	 yes	
105	 -1	 Succ=		 yes	
106	 -1	 Mal=	 yes	
107	 -1	 Glyc=	 yes	
108	 -1	 Pcholine=	 yes	
109	 -1	 Glyc3PC=	 yes	
110	 -1	 Formate=	 yes	
111	 -1	 Acetate=	 yes	
112	 0	 Isobut=	 yes	
113	 0	 Isoval=	 yes	
114	 0	 Biomass=	 yes	
115	 0	 =Glc	 yes	
116	 -1	 Lac=	 yes	








70:	Metabolic	 requirements	 reflect	 the	 nmol	 content	 in	 106	 cells	with	 a	 CDW	 of	 271	
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